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ABSTRACT
DISTRESS, CIRCADIAN RHYTHMS, IMMUNITY, AND SURVIVAL
IN PRESURGICAL BREAST CANCER PATIENTS
Whitney Nicole Rebholz
	
  

October 10, 2016
Women with breast cancer experience significant stress related to diagnosis and

treatment, which may negatively affect physiology (e.g., circadian, endocrine, and
immune) and contribute to cancer progression. Demographic (e.g., ethnic minority) and
neighborhood factors can contribute to cancer-related stress. African American women
with breast cancer experience more adverse disease pathology and earlier mortality;
however, factors that explain these disparities rarely have been explored. It is
hypothesized that psychosocial stressors (i.e., ethnicity, neighborhood stress, and cancerrelated stress) will be related to one another. Associations of psychosocial stress with
physiological disruption are posited with regard to circadian, endocrine, and immune
function. It is also hypothesized that psychosocial stress and physiological disruption will
predict earlier cancer recurrence/mortality.
Presurgical breast cancer patients (N=57) reported on demographics and cancerrelated stress and provided three-day home-based collection of rest/activity rhythms and
salivary cortisol. Neighborhood stress data were obtained via the 2010 Census. Immune
parameters were assessed in serum samples. Progression-free survival status was
obtained at a median of seven years post-enrollment.
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Bivariate correlations examined relationships between psychosocial stressors.
Hierarchical linear regressions adjusted for age, cancer stage, and income in tests of
associations between psychosocial stress and physiological disruption. Cox proportional
hazards analyses tested the prognostic value of psychosocial stress and physiological
disruption on progression-free survival from initial diagnosis and study entry.
African Americans had higher neighborhood stress compared to non-Hispanic
White patients. Patients with greater neighborhood stress had greater overall cortisol
secretion (ΔR2 = .246, p = .001). Patients reporting greater cancer-related stress had
accentuated diurnal cortisol rhythms (ΔR2 = .084, p = .047). Exploratory post hoc
analyses revealed this finding was likely driven by avoidance of cancer-related thoughts.
Psychosocial stress was not significantly related to circadian or immune disruption, nor
was psychosocial stress or physiological disruption predictive of progression-free
survival.
Improved resources within disadvantaged neighborhoods may help counter the
effects of neighborhood stress on cortisol disruption by reducing stress and improving
health outcomes. Interestingly, during the acutely stressful presurgical period, avoidance
appears to serve as an adaptive coping strategy. Therefore, the presurgical period may be
the opportune time to introduce psychosocial interventions to combat challenges
throughout one’s cancer journey.
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INTRODUCTION

Breast Cancer
Incidence, risk, and mortality. Breast cancer is the most common cancer
diagnosed in women and accounts for approximately 29% of new female cancer
diagnoses (Siegel, Ma, Zou, & Jemal, 2014). In the 1980s, rates of breast cancer
increased dramatically, primarily due to better detection through utilization of
mammography (DeSantis, Ma, Bryan, & Jemal, 2014). Increases in rates of obesity and
use of menopausal hormones, both of which are breast cancer risk factors, partly explain
a small increase in incidence rates in the late 1990s (DeSantis et al., 2014). In the early
2000s, the rates of breast cancer incidence dropped drastically, most likely due to a
decrease in the use of hormone replacement therapy following a Women’s Health
Initiative publication (DeSantis et al., 2014). The current risk of being diagnosed with
breast cancer is 1 in 8 for women living in the United States (DeSantis et al., 2014).
Incidence rates of breast cancer have remained stable over the past decade (Siegel et al.,
2014).
Breast cancer is the second most common cause of death from cancer among
women, accounting for 15% of cancer deaths in women (Siegel et al., 2014). Among
women aged 20 to 59, breast cancer is the leading cause of cancer death (Siegel et al.,
2014). However, rates of mortality from breast cancer have been declining, particularly
due to improvements in detection and treatment (DeSantis et al., 2014). 	
  

	
  

1

	
  
Breast cancer types. There are different types of breast cancer, which are
classified based on the origin and spread of cancer. Ductal carcinoma in situ (DCIS) is
noninvasive carcinoma, meaning cancer occurs within the breast ducts and has not spread
beyond the duct of origin (Van Goethem et al., 2006). Invasive breast carcinoma
indicates that cancer has spread beyond the site of origin (e.g., duct or lobule) and into
the surrounding breast tissue (Andersson, 2005). Invasive carcinomas often develop from
DCIS. When cancer has spread to distant tissue and organs, it is considered metastatic
disease.
Breast tumors can be classified as a carcinoma or sarcoma. Carcinoma is the most
common type of breast cancer, which indicates that the cancer originated in the epithelial
cell lining of breast tissue (Andersson, 2005). Sarcomas, which arise from the
mesenchymal tissue of the breast (Adem, Reynolds, Ingle, & Nascimento, 2004), account
for less than one percent of breast cancer diagnoses (Pandey, Mathew, Abraham, &
Rajan, 2004).
Disease staging. Breast cancer is staged in order to measure the extent of the
disease. The tumor-node-metastasis (TNM) staging system is widely used and is based on
the size of the tumor, the presence of metastasis to lymph nodes, and the presence of
distant metastases (Singletary et al., 2002). Stages of breast cancer range from 0 to IV.
Stage 0 is a mass that has not yet spread beyond the lobule or duct where it originated,
which is referred to as carcinoma in situ. Stage IV is cancer that has spread to distant
organs of the body.
Hormone status. Determining the hormone receptor status of breast cancer cells
has become a common practice, as there are implications for treatment options and
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predictions of subsequent survival time based on the presence or absence of certain
hormone receptors. The status of three receptor types is determined using tumor tissue
samples, taken during diagnosis of breast cancer. These are estrogen receptor (ER),
progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). The
most common combination is ER/PR positive (+) and Her2 negative (-) (68.9%; Onitilo,
Engel, Greenlee, & Mukesh, 2009). The absence of all three hormone receptors is known
as “triple negative” breast cancer. For an individual diagnosed with triple negative
cancer, there are fewer treatment options, as receptor-targeted hormone therapy is not
effective with these cases (Bauer, Brown, Cress, Parise, & Caggiano, 2007). Triple
negative status is associated with the shortest survival rate (Onitilo et al., 2009). The
prevalence of various hormone receptor types varies across racial/ethnic groups. Triple
negative breast cancer is highest among African American women (Bauer et al., 2007).
Treatment options. Multiple standard treatments are used to treat the different
stages and types of breast cancer (Carlson et al., 2011). Localized disease is treated with
surgery, radiation therapy, or both, whereas widely invasive or metastatic disease is
treated with chemotherapy, endocrine therapy, biologic therapy, or combination therapy
(Carlson et al., 2011). Surgery is performed in order to remove cancer from the breast.
One type of surgery is breast-conserving, (e.g., lumpectomy or partial mastectomy),
indicating that tumor is removed but the entire breast is not (Parajuli, 2015).
Alternatively, patients may opt for total mastectomy, which is the surgical removal of the
entire breast (Parajuli, 2015). Chemotherapy, the use of systemic drug treatment to either
kill cancer cells or inhibit their division, may be used prior to surgery, a strategy known
as neoadjuvant treatment (Parajuli, 2015). Chemotherapy is used to reduce the tumor size
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and therefore the amount of tissue to be removed at the time of surgery (Parajuli, 2015)
Chemotherapy and/or radiation therapy, the use of radiation to kill or shrink cancer cells,
may be used after surgical treatment (Jacobs & Finlayson, 2010). Endocrine therapy is a
treatment that blocks the effects of naturally occurring hormones that stimulate the
growth of breast tissue (e.g., estrogen; Miller & Ingle, 2002). Biologic therapy is drug
treatment that activates the immune system to inhibit tumor growth and spread (Vachani
& Millar, 2015) and includes HER2-targeted therapy (Carlson et al., 2011).
Psychological symptoms. Breast cancer can be thought of as a series of stressors
that relate to diagnosis, treatment, reduction in functional ability, changes in social and
vocational roles, and concerns related to morbidity and mortality (Spiegel & Sephton,
2001). Psychological distress can manifest as depressive symptoms, anxiety, insomnia,
and increasing social isolation; all of which are common following a cancer diagnosis
(Mertz et al., 2012). In a study of women with breast cancer, clinically significant levels
of either anxiety or depression were observed in 34% of patients two months following
diagnosis (Gallagher, Parle, & Cairns, 2002). These symptoms decreased by six months
post-diagnosis; however, rates of psychological illness remain higher among cancer
patients in comparison with those of the general population (Gallagher et al., 2002).
Additionally, women newly diagnosed with breast cancer experience greater role
limitations related to emotional difficulties than those with stable disease (i.e., women
who have completed adjuvant treatment and are at least six-month post-diagnosis, and
women who have not experienced a recurrence; Hanson Frost et al., 2000).
Tumor progression.	
  The spread of cancer from the primary site to lymph nodes
and distant organs constitutes metastatic disease. Cancer cells and associated tissue
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develop “Hallmark” capabilities that promote tumor growth and spread (i.e., movement
out of the site of origin into other tissues; Hanahan & Weinberg, 2011). Many steps are
essential for cancer to metastasize, including proliferation (i.e., growth or production of
cancer cells; Guo & Hay, 1999), angiogenesis (i.e., development of a blood supply;
Lutgendorf, Sood, & Antoni, 2010), detachment, and invasion (i.e., cancer cells must
separate from their site and move through the body in order to invade other organs;
Armaiz-Pena, Cole, Lutgendorf, & Sood, 2013). Embolism, circulation, stopping in an
organ and adhering to vessel walls, extravasation (i.e., the movement of cells from blood
vessel to tissue; Miles, Pruitt, Golen, & Cooper, 2007), and the establishment of a tumor
microenvironment, and blood supply (Fidler, 2003; Hanahan & Weinberg, 2011) are also
steps needed for metastasis. Additionally, cancer cells must evade growth suppression,
immune destruction, and apoptosis and stimulate inflammation that helps to promote the
tumor (Hanahan & Weinberg, 2011). Metastatic tumors are responsible for 90% of cancer
deaths, as compared with primary tumors (Sporn, 1996).	
  
Stress and Health
Psychological stress is defined as the appraisal of an event or circumstance as
demanding or overwhelming to the point that coping resources will be taxed or exceeded
(Lazarus & Folkman, 1984). Neuroendocrine and immune stress responses that function
in a normal manner (i.e., activated in response to threats to survival) are essential to
leading a healthy life. Under acute stress conditions, these systems serve protective
functions for the human body. However, when stress responses are frequently and
repeatedly activated over an extended period (i.e., chronically activated), elevations in
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exposure to stress hormones occur and may have detrimental effects on other body
systems causing a loss of flexibility of biologic responses to stress (McEwen, 1998).
When stress responses are chronically activated, a buildup of physiological
damage can occur (McEwen, 2006), leading to stress-related diseases (Sapolsky, 2004).
Specifically, chronic stress can affect biological processes (i.e., neuroendocrine and
immune responses) that influence cancer progression (i.e., metastasis; Moreno-Smith,
Lutgendorf, & Sood, 2010). A biobehavioral model (Andersen, Kiecolt-Glaser, & Glaser,
1994) indicates that cancer diagnosis and treatment can serve as a stressor sufficient to
impact tumor growth and immune defenses through overactivation and dysregulation of
neuro-endocrine-immune pathways, promoting the progression of cancer (Andersen et
al., 1994).
Stress Related to Ethnicity
A person’s ethnicity, and their identification with their ethnicity, can contribute to
psychological stress. Racial or ethnic identification is defined as the “cognitive-affective
representation of ethnic group membership within a person” (Contrada et al., 2001, p.
1779). Ethnicity-related stress can be defined as the appraisal of the environment with
regard to one’s ethnicity, which may lead to the anticipation of harm, either physical or
psychological, or to the belief that harm has already occurred (Contrada et al., 2001).
A review article described three contributing factors to ethnicity-related stress:
ethnic discrimination (i.e., unfair treatment of an individual based on their race/ethnicity),
stereotype threat (i.e., the risk of conforming to a negative stereotype for the group that
one belongs to), and own-group conformity pressure (i.e., being pressured to comply with
expectations from the group that one identifies with; Contrada et al., 2000). Ethnicity-
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related stress may develop in response to a number of events, such as believing that there
are threats to one’s self-esteem, recognizing a lack of normalization by the group to
which one belongs, and experiencing hopelessness related to one’s ethnic identification
(Clark, Anderson, Clark, & Williams, 1999). Additionally, maintaining one’s ethnic or
cultural identity may contribute to stress due to pressure to conform to the group to which
one belongs or to conform to the perceptions of norms and expectations of the in-group
(Contrada et al., 2000). However, ethnic identity has also been shown to be positively
related to quality of life (QOL) and overall well-being (Utsey, Chae, Brown, & Kelly,
2002). Therefore, it is important to delineate what aspects related to ethnicity (e.g., racial
discrimination) contribute to ethnicity-related stress and what facets may enhance wellbeing.
Certain life stressors are more often experienced in ethnic minority groups, which
may promote stress in these individuals. These stressors are largely based on
socioeconomic disadvantages (Lillie-Blanton & Laveist, 1996; Harrell, 2000). As is well
known, socioeconomic status (SES) covaries with ethnicity. Generally, SES can be
characterized as a measure of opportunities, both educational and economic, that are
available in an individual’s environment (Lillie-Blanton & Laveist, 1996). In a large
longitudinal study that followed Baltimore schoolchildren for years, in adulthood the
African American men earned less and had lower employment than the non-Hispanic
(NH) White men with equal educational attainment (Alexander, Entwisle, & Olson,
2014). Additionally, African Americans were more likely to be single parents, and while
African American women earned similar income to NH White women, because of the
larger number of African American single-mother households, the family income was
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substantially lower compared to NH Whites (Alexander et al., 2014). Although all
participants in the study were socioeconomically disadvantaged, it was determined that
NH White participants had access to greater resources, especially with respect to
obtaining employment, and these resources may be beneficial in creating a pathway
toward better SES over time (Alexander et al., 2014). In a study of NH White and
Hispanic lesbian, gay, and bisexual individuals an association between ethnicity and
perceived stress was observed, and this relationship was mediated by SES, as well as
lifetime discrimination (Kim & Fredriksen-Goldsen, 2016). Furthermore, ethnic
minorities experience greater perceptions of stress related to employment, financial
strain, life discrimination, job discrimination, relationships, and early life (Sternthal,
Slopen, & Williams, 2011).
A biopsychosocial model of perceived racism can further illuminate the effects of
ethnicity-related stress. Sociodemographic, psychological, and behavioral factors, as well
as coping resources, interact in response to the perception of racial discrimination,
playing a vital role in the impact of ethnicity-related stress on health outcomes (Clark et
al., 1999). Both negative physical and psychological health outcomes have been observed
in those who experience perceived racism (Clark et al., 1999) and ethnicity-related
stressors (Contrada et al., 2000). Additionally, effects of both intergroup and intragroup
racism may culminate in adverse health outcomes (Clark et al., 1999). Perceived racial
discrimination has been shown to be associated with psychological distress (Sellers,
Caldwell, Schmeelk-Cone, & Zimmerman, 2003; Kessler, Mickelson, & Williams, 1999),
as well as depressed mood and anxiety (Kessler et al., 1999). The accumulation of
ethnicity-related stress along with other general stressors may deem ethnic minorities at
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greater risk for mentally and physically detrimental effects than those who are within the
ethnic majority, for example, NH Whites in the United States. In a sample of first year
African American medical students, those with lower racial identification were less likely
to endorse depressive and anxiety symptoms (Hardeman et al., 2016).
Disparities exist among ethnic minority groups in health status, morbidity, and
mortality (Myers, 2009). It has been shown that ethnic differences in disease relate more
to underlying social conditions (i.e., childhood poverty, inadequate education, low
income, minimal employment, and separated living conditions), rather than to behavioral
differences (e.g., coping style; Harrell, 2000). Socioeconomic factors also contribute
substantially to ethnic health disparities (Lillie-Blanton & Laveist, 1996). Also, ethnic
health disparities may be due to one’s surroundings (i.e., neighborhood and work
conditions), social relations, and power arrangements (i.e., individual and community
control and influence; Lillie-Blanton & Laveist, 1996).
Ethnic minorities differ from the majority in the trajectory of chronic disease and
in response to treatment (Myers, 2009). Ethnicity-related stress has been shown to
accelerate the progression of a number of diseases, one of which is cancer (Myers, 2009).
Specifically, adverse disease outcomes occur at higher rates in ethnic minorities, with
African Americans experiencing the greatest burden (Myers, 2009). Breast cancer
incidence is highest among NH Whites, but African Americans suffer the highest
mortality (DeSantis et al., 2014). Additionally, in comparison with NH Whites, African
American breast cancer patients are more likely to be diagnosed at an earlier age, and are
diagnosed with more advanced stage disease or more aggressive cancer types (Middleton
et al., 2003).
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Access to health care and receipt of treatment do play a role in the association
between ethnicity and cancer. Ethnic minorities experience disparities in receipt of
definitive primary (i.e., surgery and radiation) therapy, conservative surgery, and
adjuvant treatments (i.e., chemotherapy and hormonal therapy; Shavers & Brown, 2002).
Additionally, NH Whites are more likely to receive aggressive cancer treatments
(Shavers & Brown, 2002). Evidence suggests there are relatively fewer ethnic differences
in health care access in systems with universal accessibility (i.e., Department of Defense),
supporting the notion that poor access may be a major determinant of ethnic differences
in health outcomes (Mayberry, Mili, & Ofili, 2000). Concerning cancer outcomes, the
literature is less clear due to a lack of treatment data and limited quality of previous
research (Mayberry et al., 2000). Therefore, further research should more broadly explore
factors that contribute to the relationships observed between ethnicity and cancer to better
understand ethnic differences in clinical characteristics (e.g., age and stage at diagnosis),
as well as differences in treatment modalities and outcomes (e.g., morbidity and
mortality).
Some data suggests that ethnic differences in health behaviors also explain a
portion of the differences in cancer progression. A telephone survey of 42,044
households revealed that, in general, African Americans are more likely to smoke, report
a lack of physical exercise, and be overweight compared to NH Whites (Shariff-Marco,
Klassen, & Bowie, 2010), all of which enhance the risk of breast cancer. Compared to
NH Whites, Latino participants were more likely to binge drink and be overweight, Asian
American participants were more likely to be less physically active, and American
Indian/Alaskan Native participants were more likely to smoke, binge drink, report a lack
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of physical exercise, and be overweight (Shariff-Marco et al., 2010). These health
behaviors may contribute to cancer progression (Calle, Rodriguez, Walker-Thurmond, &
Thun, 2003; Tammemagi, Neslund-Dudas, Simoff, & Kvale, 2004; Vucenik & Stains,
2012). The possible effect of health behavior differences on cancer outcomes is a nascent
research area.
It is also possible that genetic differences related to ethnicity may explain some
disease outcome variance. Indeed, genetic factors can interact with environmental ones to
produce discrepancies in health outcomes (Caspi et al., 2003).Thus, gene-environment
interactions related to alleles more prevalent in ethnic minorities may potentially explain
some ethnic differences in cancer outcomes (Braun, 2002).
Research has primarily focused on perceived racism/racial discrimination as
determinants of ethnicity-related stress. While this research aids in understanding
interactions of ethnicity and stress, there are additional areas that warrant attention.
Perceived stress in relation to minority ethnic identification should be investigated, as
understanding these associations may help in identifying ethnic differences in the
perception of stress. Additionally, exploring ethnicity-related stress and health outcomes
may help to elucidate potential mechanisms that drive ethnicity-related health disparities.
Neighborhood Stress
Research has shown that neighborhood disadvantages may impact health more
than individual socioeconomic and demographic factors (Ross & Mirowsky, 2001).
Neighborhood-level variables may include the built environment (e.g., the presence of
toxic waste facilities, traffic exposure, and medical infrastructure; Matthews & Yang,
2010). Additionally, neighborhood safety, residential stability, and measures of social
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disadvantage, including poverty, unemployment, and receipt of public assistance are
considered social characteristics of neighborhoods (Matthews & Yang, 2010).
Neighborhood factors can be viewed as a source of chronic stress that may have
an adverse impact on health (Steptoe & Feldman, 2001). Neighborhood factors that may
influence the health of residents include the percentage of people that are poor, lack of
education, are unemployed, and the percent of single mother households (Hill, Ross, &
Angel, 2005). In low socioeconomic neighborhoods, there are greater rates of cancer
(Adler, Boyce, Chesney, Folkman, & Syme, 1993). Furthermore, research has shown that
even though the relationship between neighborhood-level stress and health of the
residents has been established, the mechanisms of this relationship remain underexplored
(Ellen, Mijanovich, & Dillman, 2001; Ross & Mirowsky, 2001).
Environmental stressors may “get under the skin” by way of psychological,
physiological, and behavioral pathways. Indeed, unstable neighborhoods (i.e., high
turnover and low homeownership), appear to negatively influence the health of the
residents (Boardman, 2004). Given the importance of stress in the progression of cancer,
it will be very informative to consider the role neighborhood factors in stress-cancer
associations.
Cancer-Related Stress
Acute stress disorder (ASD) and post-traumatic stress disorder (PTSD) are
classified as trauma- and stressor-related disorders in the fifth edition of the Diagnostic
and Statistical Manual of Mental Disorders (DSM 5; American Psychiatric Association,
2013). ASD and PTSD are diagnosed after the development of a constellation of
symptoms (i.e., intrusions, avoidance, negative alterations in mood or cognition, and
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changes in arousal or reactivity) following a traumatic event (American Psychiatric
Association, 2013). In ASD the symptoms are present from three days to one month after
the traumatic event, whereas PTSD is diagnosed when the symptoms endure longer than
one month (American Psychiatric Association, 2013). It is important to note that DSM-IV
allows for a life-threatening illness as a traumatic stressor; however, with changes to
DSM-5, life-threatening illnesses are no longer considered a traumatic stress event
(Swartzman, Booth, Munro, & Sani, 2016). Therefore, it is possible that individuals with
cancer may experience symptoms of PTSD (e.g., intrusions or avoidance) and no longer
meet diagnostic criteria for PTSD.
Cancer-related stress differs from ASD and PTSD, as both are mental disorders
recognized in DSM-5, whereas cancer-related stress is not a diagnosable mental disorder.
Cancer-related stress includes two symptoms of PTSD, intrusions and avoidance.
Intrusions include intrusive thoughts, nightmares, intrusive imagery, and dissociative-like
re-experiencing, whereas avoidance includes numbing of responsiveness and avoiding
feelings, situations, and ideas (Horowitz, Wilner, & Alvarez, 1979). The presence of both
symptoms indicates elevated cancer-related stress and more severe impact of illness
(Mcbride, Clipp, Peterson, Lipkus, & Demark-Wahnefried, 2000). Cancer-related ASD,
cancer-related PTSD, and cancer-related stress have been observed throughout the breast
cancer trajectory.
In a sample of 85 newly diagnosed (i.e., average of 11.65 days after diagnosis)
breast cancer patients, those who experience high levels of intrusions or both intrusions
and avoidance had the poorest psychological adjustment to diagnosis (Primo et al., 2000).
In contrast, those who reported low levels of both symptoms had the lowest level of
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depressive and anxiety symptoms at six-month follow-up (Primo et al., 2000). In a study
of 166 breast cancer patients, four met criteria for cancer-related ASD and two met
criteria for cancer-related PTSD after diagnosis and prior to surgery (i.e., lumpectomy or
mastectomy; Voigt et al., 2016). After chemotherapy (i.e., seven and one-half months
after baseline assessment) and one year after baseline assessment, three of the patients in
the study met criteria for either cancer-related ASD or cancer-related PTSD (Voigt et al.,
2016). Of note, while not meeting criteria for ASD or PTSD, 82.5% of patients endorsed
cancer-related PTSD symptoms at baseline, and 57.3% endorsed symptoms at one-year
follow-up (Voigt et al., 2016). In a sample of 437 women with breast cancer, three
percent (n=13) met criteria for PTSD, diagnosed with a Structured Clinical Interview for
DSM-IV, at baseline (i.e., average of 65.4 days after diagnosis; Kwakkenbos, Coyne, &
Thombs, 2014). At three month follow-up, nine patients met criteria for PTSD
(Kwakkenbos et al., 2014). One-hundred seventeen patients with primary breast cancer
within six months of a diagnosis experienced cancer-related stress at a level that is
moderately high (Koopman et al., 2002). In a sample of 150 women with breast cancer,
high levels of intrusions and avoidance following diagnosis and prior to surgery remained
two years later (Arnaboldi et al., 2014).
Women with metastatic breast cancer also report high rates of intrusions and
avoidance, rates that are comparable to those who have had experienced other traumatic
stressors such as survivors of multiple shootings and motor vehicle accidents (Butler,
Koopman, Classen, & Spiegel, 1999). However, it appears that levels of cancer-related
stress are lower among women with primary breast cancer (Koopman et al., 2002a) as
compared with metastatic patients (Butler et al., 1999). In a sample of women who had
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completed treatments for breast cancer, five to ten percent met criteria for the diagnosis
of cancer-related PTSD (Cordova et al., 1995). A recent meta-analysis revealed that
survivors of cancer are 1.66 times more likely to have PTSD than controls without cancer
(Swartzman et al., 2016).
Possible factors that may increase the likelihood of cancer-related PTSD include
younger age at diagnosis, receiving chemotherapy, and time since diagnosis (i.e., PTSD
rates appear to decrease over time; Swartzman et al., 2016). Cancer-related stress has
been shown not to be associated with time since diagnosis (Mcbride et al., 2000). It
appears that cancer-related stress is present from the time of a breast cancer diagnosis and
remains throughout the treatment trajectory. Therefore, the stress associated with a breast
cancer diagnosis may be psychologically impactful and salient in the long-term for the
patient, rather than only present initially following the diagnosis (Mcbride et al., 2000).
Circadian Rhythms
Healthy circadian regulation. Human physiology is synchronized with the
rotation of the earth by the hypothalamic suprachiasmatic nuclei (SCN). The central
circadian clock, located in the SCN, synchronizes the peripheral clocks of most
mammalian cells through an array of circadian physiological rhythms that include
rest/activity rhythms, hormonal secretions, body temperature, and feeding (Mohawk,
Green, & Takahashi, 2012; Schibler et al., 2015). Light-dark cycles are the strongest
zeitgebers of central control over peripheral rhythms (Schibler et al., 2015). The
traditional view of the relationship between the SCN and the peripheral cellular clocks is
believed to be hierarchal in nature, with the central clock of the SCN regulating the
timing of peripheral clocks; however, recent research is beginning to show that the
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relationship may be more “federated,” such that various oscillators are equal to one
another (Husse, Eichele, & Oster, 2015, p. 1120). Therefore, it is likely that peripheral
clocks are influenced by independent zeitgebers (e.g., light-dark cycles, hormones, bloodborne signals, body temperature; Husse et al., 2015).
Circadian rhythms and cancer. Research has shown that dysregulated circadian
rhythms, specifically shift work that involves the disruption of circadian rhythms, is
probably carcinogenic to humans, which makes it a Class 2A carcinogen (Straif et al.,
2007). Shift work is associated with changes in rest/activity rhythms, such that patterns of
activity become deregulated and circadian synchronization is lost, which can lead to
dysregulation of the endocrine and immune system (Herichova, 2013). Research
regarding the prognostic value of circadian disruption and cancer risk has confirmed
higher incidence of breast cancer in nurses who worked night shift for many years
(Davis, Mirick, & Stevens, 2001; Schernhammer et al., 2001; Schernhammer, Kroenke,
Laden, & Hankinson, 2006).
Changes to circadian rhythms occur in tumor tissues, animal models with tumors,
and human cancer patients. As a tumor progresses, circadian alterations worsen
(Mormont & Levi, 1997). Research on effects of lesions to the SCN in murine models
has revealed changes to implanted tumors that result in accelerated growth and shorter
survival (Filipski et al., 2002; Filipski, Li, & Levi, 2006). When a tumor is present, it is
possible that disruption of circadian rhythms may be a response to biological effects of
the tumor, or may be the consequence of the physiological and psychological demands of
disease (Eismann, Lush, & Sephton, 2010).	
  
Circadian disruption.
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Rest/activity rhythms. Rest/activity rhythms, patterns of activity levels over
multiple days, are strong indicators of central clock activity and have been shown to be
related to cancer outcomes (e.g., QOL and survival; Mormont & Waterhouse, 2002).
Circadian rhythms can be measured noninvasively in humans through the use of wristworn accelerometers, known as actigraphs. While polysomnography is widely considered
the “gold standard” in measuring sleep and related variables, actigraphy is a valid and
reliable approach to measuring rest/activity rhythms (Ancoli-Israel et al., 2003). Given its
portability, this method is often preferred in research.
Rest/activity rhythms have been shown to be disturbed prior to and during
chemotherapy treatment in women with breast cancer (Ancoli-Israel et al., 2006; Savard
et al., 2009). Additionally, women with metastatic breast cancer have dysregulated
rest/activity rhythms (Koopman et al., 2002). While relationships have been observed
between rest/activity rhythms, QOL, and cancer survival in colorectal samples
(Innominato et al., 2009; Lévi et al., 2014; Mormont et al., 2000; Mormont &
Waterhouse, 2002), limited research has been conducted in breast cancer samples. In a
sample of 57 presurgical breast cancer patients, no relationship was observed between
rest/activity rhythms and QOL (Rebholz et al., 2016). Continued research exploring the
relationship between rest/activity rhythms and cancer outcomes (i.e., QOL and survival)
within breast cancer patients may be beneficial in understanding relationships between
rest/activity rhythms and cancer outcomes and mechanisms that may contribute to the
associations. Additionally, research with this focus may help in identifying whether
changes occur throughout the cancer trajectory (e.g., presurgical, between surgery and
adjuvant treatment, during adjuvant treatment, and after the completion of treatment).
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Hypothalamic pituitary adrenal (HPA) axis. The HPA axis is one of the two
major physiological stress responses systems. It is likely a zeitgeber by which the SCN
coordinates peripheral oscillators, and loss of its circadian rhythmicity is prognostic for
mortality among several cancer types (Innominato et al., 2009; Lévi et al., 2014;
Mormont, Bogdan, Cormont, Touitou, Levi, 2002; Sephton, Sapolsky, Kraemer, &
Spiegel, 2000; Sephton et al., 2013). The HPA axis is activated by perceived stress
(McEwen, 1998; Miller, Chen, & Zhou, 2007). Specifically, to maintain physiological
stability when presented with a challenge, whether real or perceived, the HPA axis is
activated. Frequent and repeated (i.e., chronic) activation of the HPA axis can lead to the
development and progression of disease, including cancer, heart disease, obesity, and
diabetes (McEwen & Stellar, 1993; Smith & Vale, 2006).
The primary glucocorticoid produced by the human body is cortisol, which rises
in the blood within a few minutes of experiencing a stressor (Jameson, 2003), and peaks
about 20 minutes after the onset of a continued stressor. The cortisol awakening response
(CAR) is a measure of HPA axis activity following awakening (Kudielka & Wüst, 2010).
A positive relationship between response to awakening and perception of chronic stress
has been observed among 100 individuals (Schulz, Kirschbaum, Prüßner, & Hellhammer,
1998), among 212 individuals chronically stressed from work overload (Schlotz, 2004),
and among 66 public school teachers (Pruessner, Hellhammer, & Kirschbaum, 1999).
CAR is only weakly associated with the response of the HPA axis to acute stress
(Kudielka & Wüst, 2010). Cortisol levels are generally low during the late evening hours,
increase rapidly in the morning prior to waking, and peak just after waking. Levels then
gradually decline throughout the day (Chan & Debono, 2010). Examining the rhythmic
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pattern of cortisol levels throughout the day yields the diurnal cortisol slope, which
reflects the rate of change of cortisol secretion. Unhealthy slopes are those that appear
consistently flat with little variance, regardless of the whether there is a high or low
intercept for the slope. In cancer patients, cortisol slopes often appear to be idiosyncratic
with erratic peaks and troughs, as well as phase changes (Touitou et al., 1995). Although
the HPA axis is under circadian control, it can also be influenced by stress and other
factors.
Immune Function
Healthy immune defenses. The immune system is the human body’s natural
defense against illness and disease, which includes a complex array of cellular responses
that are coordinated in order to protect the body. Cell-mediated inflammatory processes
are brought about by TH-1 cells (Mosmann & Sad, 1996). TH-1 cytokines may initiate
both cytotoxic and inflammatory functions, while antibody production is linked to TH-2
cytokines (Mosmann & Sad, 1996). Type 1 cytokines are classified as pro-inflammatory
and type 2 as anti-inflammatory (Elenkov & Chrousos, 1999).
Immune function and cancer. Psychoneuroimmune pathways may mediate
observed relationships between stress and cancer outcomes (Andersen et al., 1994;
Antoni et al., 2006; Eismann et al., 2010; Lutgendorf et al., 2010). The first evidence of a
link between inflammation and cancer came in the 1800s when the presence of
leukocytes was discovered in tumors (Grivennikov, Greten, & Karin, 2010). Immune
cells may impact cancer cells by producing cytokines, chemokines, growth factors,
prostaglandins, and reactive oxygen and nitrogen species (Grivennikov et al., 2010).
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Several specific immune parameters have been implicated in the relationship
between immune function and tumor progression. Vascular endothelial growth factor
(VEGF) is released by cells that are not receiving sufficient oxygen. It promotes
angiogenesis—the growth of new blood vessels— and is released by some tumors. In
ovarian cancer cells, stress-related hormones (i.e., epinephrine and norepinephrine) have
been shown to increase the production of VEGF (Lutgendorf et al., 2003). VEGF
overproduction is linked to both growth and metastasis of solid tumors (Veikkola &
Alitalo, 1999). Matrix metalloproteinase (MMP)-9 helps to facilitate tumor invasion and
metastasis, particularly in response to signals from stress hormones (Sood et al., 2006). In
the early stages of cancer, transforming growth factor (TGF)-β suppresses development;
however, the invasiveness and potential of metastasis are enhanced by TGF-β in the later
stages (Zheng, Safina, & Bakin, 2008). Large quantities of TGF-β are produced in the
tumor microenvironment, and it is generally immunosuppressive; however, the exact
means by which this cytokine interacts with the tumor is dependent upon the tumor
microenvironment and the other immune parameters that are present (Zamarron & Chen,
2011). Additionally, TGF-β serves to inhibit macrophage activation, which may decrease
production of proinflammatory immune parameters (Zamarron & Chen, 2011).
Downstream effectors of tumor growth are triggered by interleukin-6 receptor (IL-6R;
Grivennikov & Karin, 2008). Monocyte chemoattractant protein (MCP)-1 also
contributes to inflammation and the progression of tumors (Fujimoto et al., 2009).
Myeloid-derived suppressive cells and the cytokines that are secreted, including
interleukin (IL)-6, tumor necrosis factor (TNF)-α, and IL-1β, are vital in the development
of tumors (Zamarron & Chen, 2011). Additionally, immune parameters that are
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proinflammatory in nature, including IL-1β, TNF-α, IL-6, IL-12, and interferon (IFN)-γ,
promote tumors by stimulating proliferation, angiogenesis, and metastasis (Mantovani,
Allavena, Sica, & Balkwill, 2008).
Theoretical Models
It has been proposed that psychoenuroendocrine pathways, including activation of
the HPA axis, may directly or indirectly influence cancer progression (Eismann et al.,
2010). It is suggested that a relationship between the HPA axis and psychosocial factors
exist and that this relationship may influence cancer progression (Eismann et al., 2010).
Stressors, and an individual’s psychological response to stressors, can trigger
neuroendocrine activity (Antoni et al., 2006). In turn, endocrine stress responses can
impact the tumor microenvironment and promote migration and/or invasion of cancer
cells, as well as stimulate angiogenesis, and alter immune disease-resistance capability
(Antoni et al., 2006).
In a related theoretical model, it has been proposed that biobehavioral factors
influence cancer-related processes through biological, neuroendocrine, and immune
factors (Antoni et al., 2006). Such biobehavioral factors may include life stress,
psychological processes, and health behaviors (Antoni et al., 2006). A similar model
explores the relationships between psychosocial processes, biological factors, health
behaviors, life stress, and psychological interventions and posits neuroendocrine and
immune pathways leading to cancer progression and mortality (Lutgendorf & Costanzo,
2003).
These models illustrate the complexity of factors relevant to the progression of
cancer. While cancer-related stress has been explored in the context of some of these
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models, no studies have examined whether stress related to ethnicity, neighborhood
factors, and cancer-related stress may impact cancer progression via the hypothesized
pathways. Therefore, exploring the relationships of psychosocial stress and physiological
disruption with each other and in relation to cancer progression-free survival contributes
to a missing area of the literature. By better understanding these relationships within the
cancer context, there is potential to begin to elucidate factors that contribute to cancer
disparities and identify interventions that may improve quantity and/or quality of life in
patients with cancer.
Proposed Model
The proposed model (Figure 1) builds upon our lab’s prior of model of circadian
effects on tumor progression (Eismann et al., 2010). This study proposes
interrelationships of psychosocial stress related to ethnicity, neighborhood stressors, and
the cancer diagnosis and suggests specific associations between psychosocial stress,
physiological disruption, and medical outcomes of cancer (progression-free survival
time). A significant contribution of this model is the focus on multiple domains of
psychosocial and physiological distress. The measures of psychosocial stress take into
account an individual’s ethnicity; their environment, by exploring stress associated with
their neighborhood; and their individual response to a cancer diagnosis. Additionally, the
measures of physiological disruption take into account circadian rhythms measured by
rest/activity rhythms and endocrine hormone secretion, as well as functioning of the
immune system. By exploring multiple domains of stress, one can begin to investigate
what areas are most salient in cancer patients that have not yet received treatment. Given
that treatment for cancer affects biological parameters, studying presurgical patients who
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have yet to begin treatment allows for exploration of associations while the tumor is still
present and prior to biological changes brought about by treatment. This can help us to
understand the relationship between stress and physiological disruption, which can
provide strong implications for medical and psychological clinical interventions.

Figure 1. Study aims.
Ethnicity and Physiological Disruption (Figure 1 Arrow A)
Associations with circadian disruption.
Rest/activity rhythms. No research could be found exploring ethnic differences in
rest/activity rhythms. Research has focused on sleep-related ethnic differences, which is
likely correlated with rest/activity rhythms. Research has shown no differences between
ethnicities in sleep architecture (Rao et al., 1999). Other studies have demonstrated that
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African Americans had longer rapid eye movement sleep, greater total sleep time, a lower
percentage of deep sleep (Profant, Ancoli-Israel, & Dimsdale, 2002), and less slow wave
sleep (Stepnowsky, Moore, & Dimsdale, 2003). Among older adults, sleep disturbances
were associated with ethnicity, specifically with European Americans having worse sleep
disturbance (Jean-Louis et al., 2001). This is in contrast to research showing African
American older adults having more sleep difficulties, including daytime sleepiness and
problems falling asleep (Ancoli-Israel et al., 1995), difficulties initiating and maintaining
sleep, as well as early morning awakening (Jean-Louis, Kripke, Ancoli-Israel, Klauber, &
Sepulveda, 2000), short or long sleep duration (Hale & Do, 2007), greater variation in
day-to-day sleep duration, lower sleep efficiency, greater wake after sleep onset, lower
total sleep time (Lemola et al., 2013), and greater odds of daytime sleepiness (Chen et al.,
2015).
Mixed results have been observed with regard to ethnic differences in sleep.
Research has shown ethnic differences in sleep architecture and sleep, while other
research has not observed these differences. It is possible that the differences in results
are due to differences in methodology and study populations. Therefore, much research
remains in order to better elucidate the relationships between ethnicity and rest/activity
rhythms and potential factors that help to explain these relationships. Factors could
include psychosocial variables, such as racial/ethnic discrimination, or genetic factors. It
is also possible that rest/activity rhythms help to explain ethnic health disparities.
Hypothalamic pituitary adrenal (HPA) axis. Ethnic differences have been
observed in cortisol, such that, after controlling for both education and managerial status,
greater overall salivary cortisol secretion was observed for European Americans than
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African Americans (Bennett, Merritt, & Wolin, 2004). An interaction of ethnicity and
education was observed, with lower educated African American participants having
lower levels of cortisol upon awakening (Bennett et al., 2004). It is suggested that low
waking cortisol could be an indication of chronic stress which, in turn, may influence
systemic HPA axis dysregulation (Bennett et al., 2004).
Lower waking salivary cortisol and higher levels at bedtime were observed in
African Americans compared to White young adults, which is indicative of a flattened
cortisol slope (Cohen et al., 2006). Similarly, among adolescents, both African
Americans and Hispanics had flatter salivary cortisol slopes than Caucasians (DeSantis et
al., 2007). Flattened slopes were observed in African American and Hispanic middle to
older age participants, indicating the possibility that a below normal salivary cortisol
response occurs due to chronic stress (Hajat et al., 2010). Additionally, among middle to
older adults, African Americans had lower waking salivary cortisol and a slower decline
in the afternoon (Samuel, Roth, Schwartz, Thorpe, & Glass, 2016), which is indicative of
a less healthy diurnal cortisol pattern. However, no ethnic differences have been observed
in urinary cortisol levels among middle-aged adults (Masi, Rickett, Hawkley, &
Cacioppo, 2004).
Among women who were pregnant, African Americans had lower levels of
plasma cortisol, specifically with a decrease in levels from 24-26 weeks gestation to 3032 weeks gestation (Glynn, Schetter, Chicz-DeMet, Hobel, & Sandman, 2007).
Additionally, an association between cumulative stress and flat salivary cortisol rhythms
was seen in African American women who were pregnant; however, this association was
not observed in Hispanic women (Suglia et al., 2010). A possible explanation for this
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association could be due to the African American women having higher levels of stress,
or Hispanic women having greater social support coping strategies (Suglia et al., 2010).
Furthermore, salivary cortisol levels have been explored among those whom are
caregivers of individuals with dementia. Ethnicity was associated with cortisol slope with
African American caregivers having flatter slopes (McCallum, Sorocco, & Fritsch, 2006)
and in a sample of caregivers and non-caregivers, Hispanic women had flatter diurnal
cortisol slopes than NH Whites (Gallagher-Thompson et al., 2006).
Cortisol, when measured in saliva, has been shown to differ in NH Whites and ethnic
minorities, with less cortisol secretion and flattened slopes observed in ethnic minorities.
Differences in plasma cortisol levels have also been observed. However, in a study
exploring urinary cortisol, no ethnic differences were observed. This lack of a difference
in only urinary cortisol, and neither salivary nor plasma cortisol could be due to the
difference in the collection of bodily fluids in which cortisol was measured.
Associations with immune function. Ethnic differences with regard to immune
function have been explored to a limited degree. Genetic differences for cytokines have
been observed, such that African Americans have significant differences compared to NH
Whites in the distribution of polymorphic alleles for some cytokines; therefore, inheriting
certain cytokine genes may be determined in part by ethnicity and have implications for
the optimization of immunosuppressive regimes in those receiving transplants (Hoffmann
et al., 2002) and those with Hepatitis C (Zein, Germer, El-Zayadi, & Vidigal, 2004).
Genotypes that upregulate inflammation are more common in African American women
than Whites (Ness, Haggerty, Harger, & Ferrell, 2004). Additionally, among newborns,
African Americans have higher frequencies of some alleles that have been implicated in

	
  

26

	
  
cancer risk; which may help to explain disparities in the incidence of certain cancers
(Zabaleta et al., 2008).
In addition to cytokine allelic distribution differences, limited research has
explored ethnic differences in circulating immune parameters. IL-8 and granulocyte
colony-stimulating factor (G-CSF) levels were higher and neutrophil count was lower in
African participants compared to Caucasians, (Mayr et al., 2007) and greater levels of IL6 and C-reactive protein (CRP) have been observed in African Americans compared to
NH Whites (Stowe, Peek, Cutchin, & Goodwin, 2010). However, NH Whites have been
shown to have higher levels of IL-4, IL-5, IL-8, TNF-α, and IFN-γ compared to African
Americans (Pine et al., 2016). Furthermore, elevated levels of IL-1β, IL-10, TNF-α were
associated with lung cancer among African Americans and elevated levels of IL-6 and
IL-8 were associated with lung cancer in both NH Whites and African Americans (Pine et
al., 2016).
There is a dearth of literature regarding ethnic differences in immune function,
particularly circulating immune parameters. However, given the limited research, this
appears to be an area that may help to explain ethnic disparities in the development and
progression of disease. Additional research with regard to immune function and the
relationships between ethnicity and disease may help to illuminate mechanisms by which
ethnic disparities are observed, particularly in patients with cancer.
Neighborhood Stress and Physiological Disruption (Figure 1 Arrow A)
Associations with circadian disruption.
Rest/activity rhythms. Research regarding neighborhood stress and rest/activity
rhythms has not been conducted; however, is an important area to study given the
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relationships observed between chronic stress and disruption of sleep. In neighborhoods
characterized as high stress due to crime, there are more self-reported sleep difficulties
among its residents (Steptoe, O’Donnell, Marmot, & Wardle, 2008). Residents in
neighborhoods with high levels of stress based on safety, cleanliness, and noise report
worse sleep quality (Hill, Burdette, & Hale, 2009). Furthermore, sleep quality has been
shown to moderate the relationship between neighborhood stress and psychological
distress (Hill et al., 2009) and mediate the relationship between neighborhood stress and
physical health (Hale, Hill, & Burdette, 2010), as well as the relationship between
neighborhood stress and psychological distress (Hill et al., 2009).
The limited research has shown relationships between variables of neighborhood
stress and self-reported sleep. Research regarding neighborhood stress and rest/activity
rhythms may be beneficial in further understanding possible relationships. It is likely that
a variety of factors related to neighborhood stress, perceived and observed, may be
related to rest/activity rhythms, in addition to sleep. Further, there may be different types
of neighborhood stress (e.g., socioeconomic or violence) that may be more predictive of
rest/activity rhythms than others.
Hypothalamic pituitary adrenal (HPA) axis. It is possible that neighborhood
stress can influence disease through neuroendocrine pathways (Steptoe & Feldman,
2001). Flattened salivary cortisol rhythms have been observed in individuals who live in
neighborhoods with high levels of both perceived (e.g., perceived violence) and observed
(e.g., homicide rates) stressors (Karb, Elliott, Dowd, & Morenoff, 2012). Flattened
diurnal slopes and flatter decline from 30 minutes post-awakening to about two hours
post-awakening were associated with neighborhood poverty (Hajat et al., 2015). African
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Americans with high glucocorticoid genetic sensitivity living in neighborhoods with low
SES had lower waking cortisol (Coulon, Wilson, Horn, Hand, & Kresovich, 2015).
Neighborhood violence was associated with low waking cortisol; however, neighborhood
poverty associations with salivary cortisol in this sample were weaker and less consistent
(Do et al., 2011). Additionally, African American children with greater exposure to
neighborhood stress had higher levels of serum cortisol; however, this association was
not observed in European American children (Dulin-Keita, Casazza, Fernandez, Goran,
& Gower, 2012).
Previous research has shown relationships between neighborhood stress and
endocrine disruption. These associations have been seen for both perceived and observed
stressors. Given the relationships between chronic stress and dysregulation of the HPA
axis, and knowing that neighborhood stress is chronic in nature, exploring the
associations of neighborhood stress and dysregulation of the HPA axis is imperative in
understanding potential mechanisms by which neighborhood stress impacts health (Ross
& Mirowsky, 2001). Further research could help to elucidate the relationships between
neighborhood stress and cortisol, which could have strong implications for progression of
disease, including cancer.
Associations with immune function. Limited research has been conducted with
regard to neighborhood stress and immune function. In a study of African American
women, an association was seen between neighborhood SES and CRP, such that those
living in the poorest neighborhoods had worse biomarker levels compared to those living
in neighborhoods with better SES (Cozier et al., 2016). Additionally, elevated levels of
CRP were observed in children living in areas with high poverty or crime (Broyles et al.,
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2012). The relationship between elevated CRP and low neighborhood SES was also
detected in a sample of Mexican-American women (Gallo et al., 2012).
It has been suggested that immune function may be a mediating factor in the
relationship between neighborhood stress and disease (Steptoe & Feldman, 2001). By
focusing on the possibility of an association between neighborhood stress and immune
function, it may be possible to begin to better understand the role of these variables in
various disease processes, including cancer. It appears that CRP, a protein component
that elevates in concentration in the acute phase of inflammation (Koj, 1974), and
possibly other pro-inflammatory cytokines may be immune markers of interest in relation
to neighborhood stress.
Cancer-Related Stress and Physiological Disruption (Figure 1 Arrow A)
Associations with circadian disruption.
Rest/activity rhythms. Daily intrusions have been shown to be associated with
consistency of rest/activity rhythms over several days, as well as sedentary behaviors
during the day (Dedert et al., 2012). Additionally, daily avoidant coping was also
associated with consistency of rest/activity rhythms over several days, sedentary
behaviors during the day, and restlessness at night (Dedert et al., 2012). Differences in
sleep have also been observed in a sample of presurgical breast cancer patients, the night
prior to surgery intrusive thoughts were associated with less sleep duration and lower
sleep efficiency (Wright, Schnur, Montgomery, & Bovbjerg, 2010). In breast cancer
survivors, intrusive thoughts were shown to be related to self-reported symptoms of
insomnia (Taylor et al., 2012).
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Within samples of women with breast cancer and breast cancer survivors,
research has shown relationships between components of cancer-related stress (i.e.,
intrusions and avoidance) and rest/activity rhythms, sleep, and symptoms of insomnia.
More research has focused on associations with intrusions, rather than avoidance. This is
expected given the established relationship between intrusive thoughts and sleep
disturbance (Harvey, 2002; Harvey, Tang, & Browning, 2005; Wicklow & Espie, 2000).
While focusing on intrusions seems intuitive, avoidance may also be associated with
rest/activity rhythms, particularly daytime sedentariness.
Hypothalamic pituitary adrenal (HPA) axis. Cancer-related stress and its
associations with endocrine activation have also been explored. Relationships between
intrusions and alterations in endocrine activation have been observed in individuals who
have suffered a psychological trauma (Yehuda, 2002). Among healthy women, breast
cancer-specific intrusions were related to greater levels of cortisol during a work period,
which was considered a life stressor in this study (Dettenborn, James, Valdimarsdottir,
Montgomery, & Bovbjerg, 2006). In this same sample of women, daily intrusions and
daily avoidant coping was not related with measures of salivary cortisol (Dedert et al.,
2012). Exploring the relationship between cancer-related stress and endocrine disruption
allows for a better understanding of the role a cancer diagnosis and the associated
symptoms of stress plays in changes to cortisol. In turn, this may be beneficial in
elucidating effects on chronic disease.
Associations with immune function. Generally, the immune system is adaptive
and responds to various signals from the body, including distress. How the immune
system reacts is dependent upon whether the stressor is acute or chronic in nature. Acute
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stressors, which are time-limited, upregulate natural immunity (e.g., inflammation) and
suppress specific immunity (e.g., proliferation), whereas chronic stressors trigger global
immunosuppression (Segerstrom, 2004). Specifically, psychosocial stressors and
depression are associated with decreased cytotoxic T-cell and natural killer cell activities,
which influence immune processes of tumors (Reiche, Morimoto, & Nunes, 2005;
Reiche, Nunes, & Morimoto, 2004). Among breast cancer patients that have completed
surgery, cancer-related stress has been shown to be related to inhibition of cellular
immune response (Andersen et al., 1998), declines in natural kill cell activity and IFN-γ
(Von Ah, Kang, & Carpenter, 2007), and elevations of IL-1Rα (Mundy-Bosse, Thornton,
Yang, Andersen, & Carson, 2011). More research regarding the effects of cancer-related
stress, including intrusions and avoidance, and their influence on immune function may
be advantageous in understanding mechanisms of cancer progression.
Psychosocial Stress and Medical Outcomes of Cancer (Figure 1 Arrow B)
Associations with ethnicity. Much disparity exists between ethnic groups with
regard to the progression of cancer, which can encompass advanced stage disease,
metastasis, recurrence, and mortality. Data from the National Center for Health Statistics
has been compiled regarding cancer mortality rates, as well as projections for the number
of cancer deaths for the year 2014 (Siegel et al., 2014). This epidemiological data
indicates five-year survival rates are lower among African Americans than for Whites for
female breast, colorectum, esophageal, kidney and renal pelvis, liver and intrahepatic bile
duct, lung and bronchus, melanoma of the skin, non-Hodgkin lymphoma, oral cavity and
pharynx, ovary, prostate, urinary bladder, uterine cervix, and uterine corpus cancer
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(Siegel et al., 2014). The only cancer site with equal five-year survival between ethnic
groups is pancreas (Siegel et al., 2014).
By observing death rates in this epidemiological study, ethnic disparities are
evident. The death rates for cancer are 207.7 in 10,000 among African Americans and
172.4 in 10,000 among Whites (DeSantis et al., 2007). It is suggested that barriers to
care, including socioeconomic disparities, may help to explain the ethnic differences
observed in cancer outcomes; however, research has suggested that these differences
remain after controlling for such factors (DeSantis et al., 2007).
The question of ethnicity-related differences in cancer outcomes is one that is
complex in nature, specifically in that associations with minority status are not all in the
same direction. Additionally, differences in cancer outcomes may exist within our
general conceptualization of ethnic groups. For example, differences in Chinese
Americans, Japanese Americans, and Korean Americans may be observed; however, we
would conceptualize all of the three ethnic subgroups as Asian Americans. Research has
explored the differences in cancer characteristics and mortality among ethnic groups for
various cancer tumor sites.
It has been shown that African American women have a significantly greater risk
of more advanced breast cancer, as measured by larger tumors (Haas et al., 2008), more
advanced cancer stage at diagnosis (Bradley, Given, & Roberts, 2001; Haas et al., 2008;
Komenaka et al., 2010; Li, Malone, & Daling, 2003; Ooi, Martinez, & Li, 2011), higher
grade tumors (Chlebowski et al., 2005; Li et al., 2003), a higher likelihood of negative
hormone receptor status (Chlebowski et al., 2005; Komenaka et al., 2010), and greater
distant recurrences (Komenaka et al., 2010), compared to NH White women. However,
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one study found no differences in tumor size or stage among these ethnic groups
(Chlebowski et al., 2005). Furthermore, African Americans with breast cancer have been
shown to have greater disease-specific mortality (Bradley et al., 2001; Chlebowski et al.,
2005; Du, Lin, Johnson, & Altekruse, 2011; Haas et al., 2008; Komenaka et al., 2010; Li
et al., 2003; Ooi et al., 2011; Perkins, Cooksley, & Cox, 1996) and overall mortality (Du
et al., 2011; Komenaka et al., 2010), compared to NH White women.
The differences in disease-specific mortality remained after controlling for either
stage or Medicaid/Medicare status (Bradley et al., 2001), body mass index, age, tumor
stage, and whether the patient was in the observational or clinical arm of the study
(Chlebowski et al., 2005), receipt of adequate care (Haas et al., 2008), age and
employment (Komenaka et al., 2010), and stage, SES, and treatment (Perkins et al.,
1996). The differences in overall survival remained after controlling for patient
characteristics, tumor characteristics, income, poverty, education, treatment, and health
insurance (Du et al., 2011), as well as after controlling for clinical stage and age at
diagnosis (Komenaka et al., 2010). However, after controlling for age at diagnosis,
clinical stage, and hormone status, disease-specific survival was no longer significantly
different between ethnic groups and when controlling for estrogen-receptor status, overall
survival was not significantly different (Komenaka et al., 2010).
The majority of research regarding ethnic differences in cancer outcomes has
focused on differences in African American and NH White women with breast cancer.
Little research has explored ethnic differences between other cancer types or in other
ethnicities. This is an area that much improvement is needed. Epidemiological studies are
the primary method of exploring ethnic differences in cancer outcomes. Obtaining data

	
  

34

	
  
from cancer registries and surveillance programs may not be very informative, as it is
possible that considerable data is missing and the data that are available often are
dichotomous, leaving little room to conduct complex analyses. For example,
Surveillance, Epidemiology, and End Results Program (SEER) public use data often does
not contain detailed information on tumor characteristics, cancer treatment, and prognosis
(Yu et al., 2009). Data from large databases are excellent for helping to recognize areas
and trends in cancer outcomes. However, the results from such datasets should inform
cross-sectional, experimental, and longitudinal research to understand and explain ethnic
cancer disparities.
Access to care does not seam to explain much of the variance in cancer outcomes.
It appears that presenting at a later stage to physicians, which is a strong prognostic
indicator of mortality, does not explain why African Americans have poorer outcomes.
Therefore, it is not an issue of incidence, but rather other factors are playing a role in the
differences in cancer outcomes that are observed.
A theoretical model has been introduced to help elucidate racial disparities in
cancer morbidity and mortality. Several factors have been proposed to explain differences
in cancer mortality between ethnic groups. Patient factors, provider factors, and the
health system are embedded in social, economic, and the public health landscape in a
proposed model of mortality rate ratio among individuals with cancer (Blackman & Masi,
2006). Patient factors include many important features of the disparities seen in mortality,
including, among others, cultural attitudes and beliefs, being Non-English speaking, and
a delay in seeking medical care (Blackman & Masi, 2006). Additionally, more advanced
stage at diagnosis and having tumors that are more aggressive are also included
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(Blackman & Masi, 2006); however, there is little examination as to why these
differences in tumor characteristics are observed in those who are ethnic minorities.
Blackman and Masi (2006) believe that the factors above all play a role in the ethnic
differences observed in cancer outcomes. It is suggested that by implementing
interventions from the various perspectives (i.e., patient, provider, and health system)
disparities may decline.
Associations with neighborhood stress. Research has shown that there is an
interaction between individual and neighborhood SES with regard to mortality
(Winkleby, Cubbinm & Ahn, 2006). It is suggested that individuals with low individual
SES living in a neighborhood with high SES have the highest all-cause mortality rates,
presumably due to not having full access to resources in their neighborhood because of
their personal SES (Winkleby et al., 2006). However, specifics regarding mortality due to
cancer were not explored in the aforementioned study. It has been shown that individuals
living in poverty areas and who are younger, age 25 through 54, are statistically more
likely to die from cancer than those living in non-poverty areas; however, this
relationship was not observed for individuals aged 55 to 74 (Waitzman & Smith, 1998).
In a sample of women with ovarian cancer, neighborhood disadvantage was shown to be
related to higher tumor grade and neighborhood affluence was shown to be related to
more advanced tumor stage at diagnosis (Peterson et al., 2014). In a study of colorectal
and head and neck cancer patients in Taiwan, those with low individual SES living in
disadvantaged neighborhoods has the highest mortality, as did those with breast and lung
cancer with low individual SES living in advantaged neighborhoods (Chang et al., 2012).
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Interestingly, the importance of researching the neighborhood effect on mortality
has been emphasized as larger effects are observed with mortality rather than morbidity
(Ellen et al., 2001). This is due to the notion that there are only modest differences across
communities concerning specific diseases; however, the disease trajectory is significantly
informed by one’s neighborhood environment (Ellen et al., 2001). Mixed results have
been shown regarding mortality and neighborhood stress, and it appears that individual
income, and possibly the interaction with access to care and resources may help to
explain these differences. Given the significant role that neighborhood stress plays on the
health and disease processes of an individual, and knowing the link between stress and
cancer progression and mortality, examining these associations is crucial.
Associations with cancer-related stress. Limited research has been completed
concerning cancer-related stress and cancer progression and survival. Among a sample of
individuals with various types of cancer, avoidance but not intrusive thoughts were
shown to be predictive of disease progression one year after diagnosis (Epping-Jordan,
Compas, & Howell, 1994). These findings seem intuitive in that those who are avoidant
may not follow through with treatments or may not present to their physicians promptly
when symptoms of recurrence are evident. Therefore, there appear to be strong
implications for cancer-related stress regarding tumor progression and survival, which
warrant additional exploration in the hopes of better understanding the consequences of
cancer-related stress.
Physiological Disruption and Medical Outcomes of Cancer (Figure 1 Arrow C)
Associations with circadian disruption.
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Rest/activity rhythms. Research has shown that disruption of circadian rhythms
can be linked to progression of tumors as well as early mortality in cancer patients. A
literature review indicated that clock genes influence cell cycles in mammary epithelium,
which can lead to an improper division of the cells, leading to more aggressive breast
tumors (Blakeman, Williams, Meng, & Streuli, 2016). In a murine model, ablation of the
SCN resulted in the loss of circadian rhythmicity, which was associated with faster tumor
growth than in the control mice, which in turn lead to earlier mortality (Filipski et al.,
2009). Additionally, mice with tumors had increased tumor growth and shorter survival
when light/dark cycles disrupted circadian rhythms (Li & Xu, 1997). Among patients
with metastatic colorectal cancer, rest/activity rhythms have been shown to be
significantly related to survival (Innominato et al., 2009; Lévi et al., 2014; Mormont et
al., 2000). Additionally, sleep disruption was significantly predictive of survival in
women with advanced breast cancer (Palesh et al., 2014). Given the demonstrated
rest/activity rhythm relationships with survival in colorectal cancer patients, it would be
interesting to see if this relationship generalizes to other cancer populations. Additionally,
determining whether rest/activity rhythms, when measured at various time points
throughout the cancer treatment trajectory (e.g., presurgically, during adjuvant treatment,
and during survivorship), influence survival is worthy of exploration.
Hypothalamic pituitary adrenal (HPA) axis. Women with more advanced stage
ovarian cancer had higher levels of salivary cortisol in the morning and afternoon
compared to women with early stage ovarian cancer (Weinrib et al., 2010). Additionally,
when comparing cortisol levels of women with ovarian cancer to healthy controls, it has
been observed that afternoon and evening salivary cortisol is significantly higher in
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women with ovarian cancer (Weinrib et al., 2010). The afternoon cortisol levels were not
significantly higher in women with ovarian cancer compared to those with benign
disease; however, the evening cortisol levels were significantly different (Weinrib et al.,
2010). With regard to morning cortisol levels, no significant differences were observed
between any of the three groups (i.e., ovarian cancer, benign disease, healthy controls;
Weinrib et al., 2010). Among women with metastatic breast cancer, those with more
severe metastatic spread had higher mean salivary cortisol levels; however, no significant
differences were observed in mean cortisol levels of any samples collected throughout
each day between women with breast cancer and healthy controls (Abercrombie et al.,
2004).
Diurnal cortisol slopes and cancer has also been explored. Flatter diurnal salivary
cortisol slopes were observed in women with cancer compared to healthy controls;
however, no significant diurnal salivary cortisol slope differences were found in women
with more severe metastatic spread (Abercrombie et al., 2004). Among women with
ovarian cancer, no significant differences were observed between those with early or
advanced stage cancer (Weinrib et al., 2010).
Diurnal salivary cortisol slope was associated with mortality, such that those with
earlier mortality had flattened slopes, which is indicative of a lack of diurnal variation in
cortisol (Sephton et al., 2013). Additionally, flattened cortisol slopes were associated
with advanced stage lung cancer, as well as poorer performance status (Sephton et al.,
2013). This study also explored CAR and diurnal area under the curve (AUC); however,
no association was observed with these cortisol variables and survival (Sephton et al.,
2013).
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Among those with metastatic renal cell carcinoma, salivary cortisol slope was
significantly associated with survival (Cohen et al., 2012). In women with metastatic
breast cancer, similar results were observed, such that those with flattened diurnal
salivary cortisol slopes had shorter length of survival (Sephton, Sapolsky, Kraemer, &
Spiegel, 2000). Furthermore, steeper salivary cortisol slopes were associated with
metastases in the chest wall and adjacent lymph nodes rather than bone or distant organ
metastases (Sephton et al., 2000). Additionally, it has been shown that increased
nighttime cortisol levels and flattened cortisol slope were associated with early mortality
in women with ovarian cancer (Schrepf et al., 2015). However, in a sample of individuals
with metastatic colorectal cancer, neither serum total cortisol nor salivary free cortisol
were predictive of survival over a period of four-year follow-up (Mormont, Bogdan,
Cormont, Touitou, & Levi, 2002).
Clinical human research has shown that those with cancer have greater mean
cortisol levels compared to controls and those with benign disease and advanced cancer
have higher cortisol levels that those with early stage cancer. Those with cancer also have
flatter slopes compared to healthy controls. Furthermore, in differing cancer types
flattened cortisol slopes have been shown to be associated with early mortality. Literature
reviews have demonstrated that circadian disruption of endocrine rhythms exists in
patients with cancer, and this dysregulation plays a vital role in tumor burden and cancer
progression (Antoni et al., 2006; Eismann et al., 2010). Specifically, glucocorticoids may
promote cancer progression through angiogenesis, invasion, migration, and apoptosis
(Antoni et al., 2006).
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Associations with immune function. Immune parameters may act to suppress or
promote the growth of tumors. Inflammation tends to play a vital role in the growth and
spread of cancer and the interplay between tumor promoting, and tumor suppressing
immune factors help in the determination of the outcome of the tumor (Zamarron &
Chen, 2011). High peripheral levels of VEGF have been shown to be indicative of early
mortality in hepatocellular carcinoma (Jin-no et al., 1998) and gastric cancer
(Karayiannakis et al., 2002). MMP-9 plays a role in the metastasis of cancer, particularly
elevated levels are associated with rapid progression, secondary metastasis, and poorer
survival (Deryugina & Quigley, 2006). Either disruption or loss of TGF-β signaling leads
to either migration, invasion, and metastasis or rapid growth and metastasis, respectively
(Derynck, Akhurst, & Balmain, 2001).
A specific genetic polymorphism of IL-1β leads to significantly higher production
of IL-1β and shorter survival in a group of individuals with pancreatic cancer (Barber,
Powell, Lynch, Fearon, & Ross, 2000). TNF-α is involved in all processes of the
progression of tumors (Balkwill, 2006). IL-6 serves to enhance growth and progression of
tumors, as well as influences survival (Grivennikov et al., 2010). Higher IL-6 levels have
been shown to be associated with a greater number of metastatic sites in women with
breast cancer (Salgado et al., 2003) and are associated with poorer prognosis in both lung
and breast cancer patients (Hodge, Hurt, & Farrar, 2005). Increases in IL-6 may be due in
part to increased production of IL-6R (Scambia et al., 1995).
Expression of MCP-1 plays a role in the histologic grade of cancers, such that
MCP-1 negative tumors tend to be well-differentiated (Valković, Lučin, Krstulja, DobiBabić, & Jonjić, 1998). Additionally, IL-12 and IFN-γ may play a role in the progression
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of tumors (Mantovani et al., 2008). Research has shown relationships between immune
function and tumor characteristics, progression, and mortality. Therefore, continued
research may be beneficial in further understanding the relationship between immune
function and the progression of cancer, as well as survival. Exploring relationships in
individuals with active tumors prior to treatment allows for better understanding of the
role that cancer plays in associations with immune disruption, compared to treatment
effects.
Summary and Hypotheses
Health disparities, and more specifically, differences in cancer outcomes, are
increasingly reported both for ethnicity and neighborhood stress-related variables.
Additionally, research has shown a strong relationship between psychosocial stress,
physiological disruption, and disease progression, particularly within a cancer population.
However, life context (e.g., ethnicity and neighborhood-related stressors) has rarely been
explored within this framework and little research has explored relationships between
psychosocial stress and physiological disruption among individuals with cancer.
Two specific aims were explored in this dissertation: The first explored the
relationships between ethnicity, neighborhood stress, and cancer-related stress in a group
of women with breast cancer. The second aim explored the relationships between
psychosocial stress, physiological disruption, and medical outcomes of cancer
(progression-free survival time).
Aim 1. Associations between psychosocial stress measures.
Hypothesis 1A. Ethnicity and neighborhood will be significantly and positively
correlated with one another (Figure 2, Arrow A).
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Figure 2. Aim 1, associations between psychosocial stress measures.
Hypothesis 1B. Ethnicity and cancer-related stress will be significantly and
positively correlated with one another (Figure 2, Arrow B).
Hypothesis 1C. Neighborhood socioeconomic stress and cancer-related stress will
be significantly and positively correlated with one another (Figure 2, Arrow C).
Aim 2. Associations between psychosocial stress, physiological disruption, and
medical outcomes of cancer (progression-free survival).
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Hypotheses 2A. Tests of hypotheses 2 will explore associations of psychosocial
stress (i.e., ethnicity, neighborhood stress, and cancer-related stress) with physiological
disruption (i.e., circadian, endocrine, and immune; Figure 1, Arrow A).
Hypothesis 2A.1. African American ethnicity will be independently associated
with greater circadian disruption, endocrine disruption, and immune disruption (Figure
3).

Figure 3. Hypothesis 2A.1, associations of ethnicity with physiological
disruption.
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Hypothesis 2A.2. Neighborhood stress will be independently associated with
greater circadian disruption, endocrine disruption, and immune disruption (Figure 4).

Figure 4. Hypothesis 2A.2, associations of neighborhood stress with physiological
disruption.
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Hypothesis 2A.3. Cancer-related stress will be independently associated with
greater circadian disruption, endocrine disruption, and immune disruption (Figure 5).

Figure 5. Hypothesis 2A.3, associations of cancer-related stress with physiological
disruption.
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Hypotheses 2B. Tests of hypotheses 2B will explore associations of psychosocial
stress with medical outcomes of cancer (progression-free survival time; Figure 1, Arrow
B).
Hypothesis 2B.1. African American ethnicity will be independently associated
with shorter breast cancer progression-free survival time (Figure 6, Arrow 1).
Hypothesis 2B.2. Neighborhood stress will be independently associated with
shorter breast cancer progression-free survival time (Figure 6, Arrow 2).
Hypothesis 2B.3. Cancer-related stress will be independently associated with
shorter breast cancer progression-free survival time (Figure 6, Arrow 3).

Figure 6. Hypotheses 2B, associations of psychosocial stress with medical outcomes
of cancer (progression-free survival time).
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Hypotheses 2C. Tests of hypotheses 2C will explore associations of physiological
disruption and medical outcomes of cancer (progression-free survival time; Figure 1,
Arrow C).
Hypothesis 2C.1. Circadian disruption will be independently associated with
shorter breast cancer progression-free survival time (Figure 7, Arrow 1).
Hypothesis 2C.2. Endocrine disruption will be independently associated with
shorter breast cancer progression-free survival time (Figure 7, Arrow 2).
Hypothesis 2C.3. Immune disruption will be independently associated with
shorter breast cancer progression-free survival time (Figure 7, Arrow 3).

Figure 7. Hypotheses 2C, associations of physiological disruption with medical
outcomes of cancer (progression-free survival time).
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METHODS

Participants
Participants in this study were recruited as part of a previous study titled “Stress,
Coping and Sleep in Newly Diagnosed Women with Breast Cancer.” The study was
designed to understand how a breast cancer diagnosis impacts stress and the ability to
cope; therefore, participants were recruited as close as possible to their diagnosis of
breast cancer. The prior studies that utilized the data tested hypotheses that are separate
from those examined in this study. The prior studies explored relationships between daily
ratings of cancer-related stress and coping with actigraphy and cortisol measures (Dedert
et al., 2012) and the associations between social integration, support, and immune
function (serum and stimulated; Cash et al., 2015).
Women diagnosed with primary, recurrent, or metastatic breast cancer who had
not begun treatment (i.e., surgery, chemotherapy, or radiation) were eligible for
enrollment according to a protocol approved by the University of Louisville Institutional
Review Board. Inclusion criteria required that all participants be English speakers
without active psychoses.
Recruitment
Recruitment personnel (i.e., graduate research assistants from Dr. Sandra
Sephton’s laboratory) were present in the clinic of Dr. Anees Chagpar, the referring
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surgical oncologist, to recruit eligible participants. Dr. Kelly McMasters also referred
patients when Dr. Chagpar did not hold clinic. Recruitment occurred when the referring
physician was in clinic, which occurred two days per week. Therefore, recruitment took
place in two clinics, one day at the University Surgical Associates clinic and the other
day at the James Graham Brown Cancer Center. Medical records were examined to
determine which patients were possibly eligible for recruitment. Additionally, clinic
personnel would help alert research assistants to potentially eligible patients. Eligible
patients were introduced to the study by surgical oncologist, Dr. Anees Chagpar after a
biopsy to confirm diagnosis of breast cancer was completed. Patients who were not
referred during their visit to the clinic were invited to enroll by phone.
Initial recruitment occurred from May 2005 through June 2007. During this wave
of recruitment, 49 participants were enrolled and provided at least partial data on selfreport questionnaire, actigraphy, saliva, and immune measures. Complete serum immune
data was obtained from 30 participants. Incomplete immune data occurred due to
inability to complete a blood draw. A second wave of recruitment from December 2008
to February 2009 occurred to increase the sample size. An additional 11 participants were
enrolled, for a total of 60 participants.
During both waves of recruitment, 91 potentially eligible patients were referred to
the study. Five were introduced to the study; however, due to their time constraints were
not enrolled in the clinic and were unable to be reached by phone. Response burden
and/or time constraints were the reasons that 22 potential patients declined to participate.
One participant was not enrolled because of difficulties understanding data collection
procedures and low English proficiency. Additionally, one patient felt she lived too far
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away to participate, one patient was scheduled for treatment too soon to complete data
collection, and one patient declined because she was uncomfortable consenting to review
of medical records. Of the 60 participants enrolled, one participant provided no data due
to an illness, one provided no data due to time demands of having family visit, and one
was unable to complete collection due to increased time constraints following enrollment.
Seven participants provided partial self-report data, two participants experienced
problems with actiwatch recording, which prevented actigraphy data collection, one
participant did not provide saliva samples, and seven participants did not provide blood
samples. Overall, there was enough data provided by 57 participants to be included in
analyses.
Data Collection Procedures
A graduate research assistant obtained informed consent and research
authorizations per requirements of HIPAA. Study rationale and procedures were
explained and data collection materials were provided to participants. Participants were
provided with two questionnaire packets, one that contained demographic and self-report
measures and one that contained daily items to assess variables related to actigraphy (e.g.,
time going to bed and waking up) and cortisol (e.g., alcoholic and caffeinated beverage
consumption). A wrist-worn actiwatch was placed on the participant’s wrist at this time
and information was provided regarding actiwatch care (e.g., the watch was not waterresistant) and an opportunity to ask questions. The participants were asked to wear the
actiwatch for the coming three days. Participants were also provided with a saliva
collection kit, as well as a demonstration of saliva collection and an opportunity to
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practice and ask questions. Participants were asked to collect four saliva samples per day
over the next three days. Participants had blood drawn by a trained phlebotomist.
Neighborhood stress and progression-free survival data were collected at a later
date by a research assistant. The neighborhood stress data were gathered via the United
States Census. Progression-free survival data were obtained from the Kentucky Cancer
Registry (KCR).
Measures
Demographics. Participants completed a background questionnaire, which
assessed various demographic variables, including age, ethnicity, religious affiliation,
education, employment, household income, and living situation. Additionally, the
background questionnaire also assessed medical history and current medications that the
participant was taking.
Psychosocial Stress Measures
Ethnicity. Self-reported ethnicity was a categorical variable for which participants
indicated which of the following ethnicities they identified with most: non-Hispanic (NH)
White, African American, Hispanic, Asian American, Native American, and other. Out of
respect for potential ethnic/cultural differences, analyses only included those reporting
their ethnicity as NH White or African American.
Neighborhood stress. Participant addresses were provided as a part of the
demographic data collection. Data regarding each participant’s neighborhood status was
obtained from the United States Census Bureau’s 2010 census data using the participant
addresses. For each participant, the following four variables were the only neighborhood
data extracted from www.census.gov’s American FactFinder application: percentage of
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households below the poverty line, median household income, percentage of singleparent homes, and percentage of renter-occupied housing in the neighborhood. The data
was obtained at the census tract level, which is a small subdivision of a county. Sarah
Ehresman, research manager for the Kentucky State Data Center, served as a consultant
for obtaining data from the American FactFinder application by providing information
regarding geocoding and demonstrating how to use the software.
An index of neighborhood stress was created with principal components analysis
(PCA), as we believe that one factor score would be more representative of the
cumulative neighborhood stress, rather than variables used individually. Additionally, a
PCA was chosen in order to minimize the number of statistical tests that were run. To
conduct a PCA, first neighborhood stress variables were log-transformed due to
skewness, then standardized into z-scores since the four variables of neighborhood stress
are not the same scale of measurement (i.e., percentages and median values). Then factor
scores were created for each individual case with the regression method, as we expected
the variables to be correlated with one another, in SPSS using loadings from the PCA
with varimax rotation. Factor scores are the sum of the product of the factor loading and
the value of the individual variable of neighborhood stress. Factor scores were used as the
independent variable, neighborhood stress, in analyses.
Cancer-related stress. The Impact of Events Scale (IES) is a measure of a
participant’s current amount of distress related to their cancer (Horowitz et al., 1979).
The IES measures both intrusive thoughts and avoidance associated with the diagnosis
and treatment of cancer. The 15-item measure asked that participants rate the frequency
of the occurrence of each item over the past seven days on a four-point Likert scale
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ranging from “not at all” to “often.” The test-retest reliability of the total score is 0.87,
and for the intrusions and avoidance subscales 0.89 and 0.79, respectively (Horowitz et
al., 1979).
Scores greater than 19 on the IES total score are of high clinical concern
(Horowitz, 1982); however, this is an arbitrary cutoff and does not indicate a specific
clinical diagnosis (Joseph, 2000). Scores of 35 or above may be clinically significant for
the presence of symptoms of PTSD (Haagsma et al., 2012; Wohlfarth, van den Brink,
Winkel, & ter Smitten, 2003).
While there are no specific African American norms for the IES, it has been used
in studies that recruited both NH White women and African American women with
breast cancer (Cordova et al., 1995), as well as studies of only African American women
with breast cancer (Taylor et al., 2003). Therefore, it appears that this measure is
appropriate to use in exploring cancer-related stress in both NH White and African
American populations.
Circadian rhythms.
Rest/activity rhythms. Circadian rest/activity rhythms were measured via wristworn movement recording devices (Ancoli-Israel et al., 2003; MicroMini-Motionlogger;
Ambulatory Monitoring Systems, Inc, Ardsley NY). Over a consecutive period of four
nights and three days, the participants’ body movements were recorded. Participants were
asked to remove the actigraph watch when doing activities that would cause the device to
get wet. Sleep intervals for each participant were set by integrating self-reported times for
sleep onset and awakening with actigraphy data, with preference given to actigraphy data
when discrepant.
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Commercially available software was utilized to score all one-minute epochs and
the following measures were obtained: rest/activity rhythm measured by the
autocorrelation coefficient of activity measured across 24 hours, and two dichotomy
indices comparing daytime activity level to the activity level while the participant was in
bed (i.e., daytime sedentary behavior, nighttime restfulness). Rest/activity rhythm, a
measure of circadian consistency or the similarity of patterns of activity across days, was
calculated by correlating the epochs of activity during the first day of collection with the
epoch of activity at the same time on the other days. Similar activity levels evidence a
strong circadian rhythm at similar times of day, which yields a high rest/activity rhythm.
The dichotomy indices compare activity when in bed with activity when out of bed. The
dichotomy index for inactivity out of bed, which is daytime sedentary behavior, is the
percentage of activity counts out of bed that fall below the median level of activity counts
when the participant is in bed. The dichotomy index for inactivity in bed, indicative of
nighttime restfulness, is the percentage of activity counts in bed that is below the median
level of activity counts when the participant is out of bed. A higher dichotomy index
indicates more frequent inactivity. Therefore, greater daytime sedentariness is consistent
with circadian disruption, whereas greater nighttime restfulness is consistent with strong
circadian rhythmicity.
Salivary cortisol profiles. Participants provided a total of 12 saliva samples,
specifically three consecutive days at waking, 30 minutes after waking (+30), at four in
the afternoon, and immediately prior to bed. Medication Event Monitoring System
(MEMS) bottles and caps (Aardex, 2001) were used to store cotton saliva collection
swabs and recorded the exact date and time the bottle was opened. Participants were
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asked not to eat, drink, brush their teeth, use mouthwash, chew gum, or smoke for 30
minutes prior to saliva collection. Upon completion of data collection, the saliva samples
were centrifuged, aliquoted, and stored at -80° C.
Assays were conducted using an enzyme immunoassay (EIA) developed for use
in saliva (Salimetrics, Inc., State College, PA). The sensitivity of the assay was 0.003
µg/dL. To ensure accuracy between assay plates, assay reliability is measured as the
coefficient of variation (CV; mean divided by standard deviation). CVs for low and high
controls should be less than 15% and 5%, respectively. For these data, the inter-assay CV
was 10.45% for low controls and 4.03% for high controls.
The MEMS and self-reported saliva collection times were highly correlated
(Spearman’s r = .962), which suggests that the participant reports of collection times
were reliable (Kraemer et al., 2006). MEMS collection times were used when there were
discrepant reports. Additionally, actigraphy data were reviewed to examine for
discrepancies between waking and bedtime self-reports, with preference given to
actigraphy data. Collection time and cortisol values greater than four standard deviations
from the mean were considered outliers and deleted (n = 9 samples, 1.3%). Also, nonadherence to the collection time protocol resulted in deletion of the cortisol values (n =
83, 12.3%). See Dedert et al., 2012 for further details.
Cortisol values were log-transformed. The cortisol awakening response (CAR)
was calculated as the unstandardized beta of natural log-transformed cortisol regressed on
collection time and included the waking and +30 min samples. Diurnal cortisol slope was
calculated with the waking, 4:00 o’clock, and bedtime samples, excluding the +30 min
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sample, as the unstandardized beta of log-transformed cortisol regressed on collection
time. Diurnal mean cortisol was calculated using all 12 log-transformed values.
Immune function. A trained phlebotomist drew blood using an empty
Vacutainer tube. Blood was collected as close to study entry as possible, always before
surgical treatment. Circadian patterns of immune molecule release in system circulation
occur (Kronfol, Nair, Zhang, Hill, & Brown, 1997); therefore, a restriction in the timing
of the blood draw was attempted as much as possible within the limits of the schedule at
the clinic where recruitment occurred. The majority of blood draws took place in the
early afternoon (M = 1:15 PM, median = 1:32 PM) with 40 of the samples being
collected in the afternoon and 11 in the morning (Cash et al., 2015).
When the blood draw was completed, whole blood samples from the nonanticoagulant tube were centrifuged to separate serum from red blood cells. Serum, which
gives the measure of the general level of immune parameters present, was pipetted, and
aliquots were immediately frozen at -80° C until assayed.
Cytokines were analyzed using electrochemiluminescent quantitative arrays from
MesoScale Discovery (Gaithersburg, MD). Each sample was analyzed in duplicate
according to the manufacturer protocol. Assay plates were imaged on a SECTOR Imager
2400A and data were analyzed using Discovery Workbench software (MesoScale). In
addition to running all manufacturer specified controls, a pooled internal control was
used, and validation and maintenance of assay quality were assured by running additional
samples of the pooled control “spiked” with known amounts of analytes to fall within
specific regions of the standard curve.
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Factor analyses were previously completed to determine groupings of the 10
immune parameters with a data-driven approach (Cash et al., 2015). The factor score
from each of the three clusters that emerged from the exploratory factor analysis (EFA)
was utilized in analyses. Factor 1 included VEGF, MMP-9, and TGF-β and is indicative
of tumor invasion and immunosuppression. Factor 2 included proinflammatory and
chemotactic markers, including IL-1β, IL-6R, TNF-α, and MCP-1. Factor 3 included IL6, IL-12, and IFN-γ, measures of proinflammation and TH-1 type processes.
Medical outcomes of cancer (progression-free survival time) Consent was
obtained in order to access patient data from the KCR for determination of recurrent
status or survival in future analyses. Progression-free survival data were obtained from
KCR approximately five years after the last participant was recruited.
Medical records review. Functional status, measured with the Karnofsky
Performance Status scale (Schag, Heinrich, & Ganz, 1984), and information regarding
medications were collected during the initial interview. Medical charts were reviewed
after surgery in order to obtain accurate data on treatment choice and surgical pathology
information, including cancer stage and histology.
Control variables. The control variables utilized were age at time of cancer
diagnosis and cancer stage for all analyses, as both are associated with variance in the
speed of the progression of the tumor, as well as the level of associated psychosocial
stress (Andersen, Kiecolt-Glaser, & Glaser, 1994; Antoni et al., 2006). Additionally,
yearly income was controlled in all analyses as recruitment took place in two different
clinics, under the same surgical oncologist, where income varied significantly (Cash et
al., 2015; Dedert et al., 2012).
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Statistical Analyses
Data reduction and approach to analyses. All questionnaire data were manually
entered, cleaned, and examined for abnormal responses. Data were analyzed using an
exploratory/hypothesis generating approach, rather than hypothesis testing, in order to
maximize breadth of investigation to better understand the data provided by this sample
of presurgical breast cancer patients. Exploratory analyses are useful in elucidating
relationships that are not yet fully understood. However, there are drawbacks to
exploratory research, including that a significant number of analyses are likely to yield
some significant relationships that are spurious. Therefore, it is necessary to be cautious
in the interpretation of exploratory research. By hypothesis generating, a large number of
analyses were run in order to better understand and characterize associations within the
sample and to inform future directions, while taking care not to generalize outside this
sample.
Tests of hypotheses.
Preliminary Analytical Procedures. The assumption of normal distribution of
variables was evaluated by examining boxplots, histograms, and the skewness statistic.
Variables that were non-normally distributed were log-transformed. Additionally, for
variables in Hypothesis 1 that did not exhibit a normal distribution, Spearman
correlations will be used, as opposed to Pearson correlations.
Hypothesis 1A. Bivariate correlations were utilized to test the correlations
between ethnicity and neighborhood stress. A total of one correlation was used to test
hypothesis 1A.
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Hypothesis 1B. Bivariate correlations were utilized to test the correlations
between ethnicity and cancer-related stress. A total of one correlation was used to test
hypothesis 1B.
Hypothesis 1C. Bivariate correlations were utilized to test the correlation between
neighborhood stress and cancer-related stress. A total of one correlation was used to test
hypothesis 1C.
Hypothesis 2A.1. Hierarchical linear regressions were performed to determine the
relationship between ethnicity and physiological disruption. The theoretically-derived
control variables, age at diagnosis, stage, and income, were entered in the first block,
ethnicity was entered in the second block, and each physiological disruption variable was
entered separately as the outcome. A total of nine regressions were used to test
hypothesis 2A.1.
Hypothesis 2A.2. Hierarchical linear regressions were run to determine the
relationship between neighborhood stress and physiological disruption. Analyses were
completed in the same manner as hypothesis 2A.1; however, neighborhood stress was
entered into the second block as the independent variable. A total of nine regressions
were used to test hypothesis 2A.2.
Hypothesis 2A.3. Hierarchical linear regressions were conducted to determine the
relationship between cancer-related stress and physiological disruption. Cancer-related
stress was entered as the independent variable in block two, with all other variables
treated in the same manner as hypothesis 2A.1. A total of nine regressions were used to
test hypothesis 2A.3.
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Hypothesis 2B.1. Survival analyses estimate the likelihood of an event occurring
at a certain time. Participants were tracked over a period of time, with the focus on the
time at which the event (i.e., recurrence/death or last contact for those who have not
experienced recurrence or death) occurred. Therefore, time refers to the amount of time
from either date of initial diagnosis or date of study entry until the event. In Cox
proportional hazards analyses, the dependent variable is composed of two parts, the event
status (i.e., recurrence/death or no recurrence/death) and the time to the event.
A two-tailed Cox proportional hazards model was used to test the effects of
ethnicity on progression-free survival time, measured from the date of initial diagnosis
and the date of study entry. The two time variables were entered, independently, into the
time box, the event (i.e., progression-free survival status) was entered into the status box,
and the independent variable, ethnicity, was entered into block one. For significant
associations, additional tests will be completed as a check for potential confounding
variables and their effects on the findings (Kraemer et al., 2001; Kraemer et al., 2008). A
total of two regressions were used to test hypothesis 2B.1
Hypothesis 2B.2. The Cox proportional hazards model was used in survival
analyses testing the prognostic value of neighborhood stress on progression-free survival
time. The analyses were completed similarly to hypothesis 2B.1; however, for this
hypothesis the independent variable was neighborhood stress. A total of two regressions
were used to test hypothesis 2B.2.
Hypothesis 2B.3. The Cox proportional hazards model was used in survival
analyses testing the prognostic value of cancer-related stress on progression-free survival
time. For these analyses, the independent variable was cancer-related stress, and the
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analyses were conducted in the same way as hypothesis 2B.1. A total of two regressions
were used to test hypothesis 2B.3.
Hypothesis 2C.1. The Cox proportional hazards model was used in separate
survival analyses testing the prognostic value of autocorrelation coefficient, daytime
sedentary behavior, and nighttime restlessness on progression-free survival time.
Analyses were completed in the same manner as hypothesis 2B.1; however, in these
analyses, the independent variables were variables of circadian disruption (i.e.,
autocorrelation coefficient, daytime sedentary behavior, and nighttime restlessness). A
total of six regressions were used to test hypothesis 2C.1.
Hypothesis 2C.2. The Cox proportional hazards model was used in separate
survival analyses testing the prognostic value of CAR, diurnal cortisol slope, and mean
cortisol on progression-free survival time. Hypothesis 2C.2 looks at CAR, diurnal cortisol
slope, and mean cortisol as individual predictors and, as in hypothesis 2B.1, all other
variables were treated in a similar fashion. A total of six regressions were used to test
hypothesis 2C.2.
Hypothesis 2C.3. The Cox proportional hazards model was used in separate
survival analyses testing the prognostic value of three immune factors on progressionfree survival time. The analyses for hypothesis 2C.3 were conducted similarly to
hypothesis 2B.1; however, in these analyses the independent variables were the three
immune factors. A total of six regressions were used to test hypothesis 2C.3.
Power Analyses. Given that this study utilized previously collected data, post hoc
power analyses were conducted to determine that we have adequate power with the
sample size that was recruited to complete analyses. Power to detect effects is based on
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calculations using G*Power statistical software (Faul, Erdfelder, Lang, & Buchner, 2007)
for correlations and hierarchical linear regressions and XLSTAT-Power (Addinsoft,
2014) for Cox proportional hazards models. For hypothesis 1 little research was available
for the specific stressors that are included in analyses; therefore, since the profile of mood
states total mood disturbance (POM-TMD) was not be used in any analyses, the
correlation between the IES and POM-TMD was used to complete power analysis for this
hypothesis. Estimates were set at 0.354 for effect size with a sample size of 57 and α =
.05, hypothesis 1 has 80% power to detect effects (Faul et al., 2007).
Very limited research has studied the associations that are explored in hypotheses
2A.1, 2A.2, and 2A.3 and no effect size could be found in the literature that was obtained.
Therefore, estimates were set at a medium effects size of f2 = .15. With a sample size of
57 and α = .05, hypotheses 2A.1, 2A.2, and 2A.3 has 82% power to detect effects (Faul
et al., 2007).
For hypothesis 2C.2 power analysis for the Cox regression was completed in the
XLSTAT-Power program. With the event rate (i.e., recurrence/death) set at 50% and the
hazards ratio of 34867.43, the standard deviation of cortisol slope 0.062, and the
correlation between days of survival since diagnosis and cortisol slope of -0.194 (Sephton
et al., 2013), with a sample size of 57 and α = .05, the power to detect effects was 100%
(Addinsoft, 2014). Unfortunately, power analyses could not be calculated for hypotheses
2B.1, 2B.2, 2B.3, 2C.1, and 2C.3. While previous literature reports hazards ratios for
analyses between ethnicity and survival (Chlebowski et al., 2005), neighborhood stress
and survival (Waitzman & Smith, 1998), psychological distress and survival (Hamer,
Chida, & Molloy, 2009), circadian disruption and survival (Lévi et al., 2014), and
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immune function and survival (Karayiannakis et al., 2002), the additional data needed to
calculate power analyses for cox regression (i.e., standard deviation of the independent
variable and the correlation between the independent and dependent variable) was not
reported.
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RESULTS

Sample Characteristics
Sociodemographic characteristics. Study participants ranged in age from 21 to
79 years, with an average (SD) age of 52.32 (13.30) years. Participants were mostly
married (n = 17; 30.9%), divorced and still single (n = 17; 29.1%), or widowed (n = 10;
18.2%). Additionally, many participants were living with their spouse (n = 15; 27.3%),
with only their children (n = 11; 20.0%), or alone (n = 10; 18.2%) and about one third of
participants were currently renting their home (n = 19; 35.8%).
The majority of participants had received a high school diploma (n = 36; 65.5%).
Approximately 61% (n = 31) of participants were below the poverty line, with the
majority of participants indicating that their annual household income was less than
$20,000 (n = 20; 39.2%) or ranging from $20,000 - $39,999 (n = 13; 25.5%). Nearly half
of our participants were unemployed (n = 27; 47.4%) and nearly 10% (n = 5) of
participants did not have insurance. Additional and more detailed sociodemographic
characteristics are provided in Table 1.
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Table 1
Sociodemographic Characteristics
	
  
Marital	
  Status	
  
	
  	
  	
  	
  	
  Single	
  
	
  	
  	
  	
  	
  Single,	
  divorced	
  
	
  	
  	
  	
  	
  Single,	
  cohabitating	
  
	
  	
  	
  	
  	
  Married	
  
	
  	
  	
  	
  	
  Divorced,	
  remarried	
  
	
  	
  	
  	
  	
  Widowed	
  
	
  	
  	
  	
  	
  Widowed,	
  remarried	
  
Education	
  
	
  	
  	
  	
  	
  Middle	
  School	
  
	
  	
  	
  	
  	
  High	
  School	
  
	
  	
  	
  	
  	
  Associates/Technical	
  
	
  	
  	
  	
  	
  Bachelors	
  
	
  	
  	
  	
  	
  Masters	
  
	
  	
  	
  	
  	
  Doctorate	
  
Income	
  
	
  	
  	
  	
  	
  Less	
  than	
  $20,000	
  
	
  	
  	
  	
  	
  $20,000	
  -‐	
  $39,999	
  
	
  	
  	
  	
  	
  $40,000	
  -‐	
  $59,999	
  
	
  	
  	
  	
  	
  $60,000	
  -‐	
  $79,999	
  
	
  	
  	
  	
  	
  $80,000	
  -‐	
  $99,999	
  
	
  	
  	
  	
  	
  $100,000	
  and	
  above	
  
Employment	
  
	
  	
  	
  	
  	
  Currently	
  Employed	
  
	
  	
  	
  	
  	
  Not	
  Currently	
  Employed	
  
Living	
  Situation	
  
	
  	
  	
  	
  	
  Living	
  alone	
  
	
  	
  	
  	
  	
  Living	
  with	
  spouse/partner	
  only	
  
	
  	
  	
  	
  	
  Living	
  with	
  spouse/partner	
  and	
  child(ren)	
  only	
  
	
  	
  	
  	
  	
  Living	
  with	
  child(ren)	
  only	
  
	
  	
  	
  	
  	
  Living	
  with	
  other	
  relatives	
  
	
  	
  	
  	
  	
  Living	
  with	
  non-‐relatives	
  
	
  	
  	
  	
  	
  Other	
  
Own	
  or	
  Rent	
  Home	
  
	
  	
  	
  	
  	
  Own	
  
	
  	
  	
  	
  	
  Rent	
  
Poverty	
  Line	
  
	
  	
  	
  	
  	
  Above	
  
	
  	
  	
  	
  	
  Below	
  
Insurance	
  Status	
  
	
  	
  	
  	
  	
  Private	
  
	
  	
  	
  	
  	
  Public	
  
	
  	
  	
  	
  	
  Other	
  
	
  	
  	
  	
  	
  None	
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Frequency	
  
	
  
7	
  
16	
  
1	
  
17	
  
3	
  
10	
  
1	
  
	
  
3	
  
36	
  
5	
  
5	
  
4	
  
2	
  
	
  
20	
  
13	
  
5	
  
4	
  
4	
  
5	
  
	
  
30	
  
27	
  
	
  
10	
  
15	
  
7	
  
11	
  
8	
  
2	
  
2	
  
	
  
34	
  
19	
  
	
  
20	
  
31	
  
	
  
24	
  
9	
  
13	
  
5	
  

Percent	
  
	
  
12.7%	
  
29.1%	
  
1.8%	
  
30.9%	
  
5.5%	
  
18.2%	
  
1.8%	
  
	
  
5.5%	
  
65.5%	
  
9.1%	
  
9.1%	
  
7.3%	
  
3.6%	
  
	
  
39.2%	
  
25.5%	
  
9.8%	
  
7.8%	
  
7.8%	
  
9.8%	
  
	
  
52.6%	
  
47.4%	
  
	
  
18.2%	
  
27.3%	
  
12.7%	
  
20.0%	
  
14.5%	
  
3.6%	
  
3.6%	
  
	
  
64.2%	
  
35.8%	
  
	
  
39.2%	
  
60.8%	
  
	
  
47.1%	
  
17.6%	
  
25.5%	
  
9.8%	
  

	
  
Clinical characteristics. The majority of participants had stage I (n = 25; 42.4%),
primary (n = 52; 88.1%) breast cancer. Additionally, 77.4% (n = 41) of participants had
positive ER status, 75.0% (n = 39) had positive PR status, and almost 90% (n = 42) had
Her2Neu negative status, which is reflective of the most common hormone status
combination (Onitilo et al., 2009). Furthermore, eight participants (17.0%) had triple
negative status, for which there are fewer treatment options (Bauer et al., 2007) and is
linked to shorter survival time (Onitilo et al., 2009). The primary treatment of choice was
mastectomy (n = 49; 94.2%), while the remainder chose lumpectomy. The Karnofsky
Performance Status scale provides a rating of patient’s functional status (Schag et al.,
1984) with scores ranging from 100 (no evidence of disease or impairment from disease)
to 0 (deceased). The majority of patients’ functional status was rated as no evidence of
disease or impairment from disease (i.e., Karnofsky = 100; n = 23; 44.2%) or minor signs
or symptoms of disease (i.e., Karnofsky = 90; n = 20; 38.5%), suggesting there was
minimal to no impairment due to disease symptomatology. Additional clinical
characteristics are presented in Table 2.
Table 2
Clinical Characteristics
Age	
  at	
  Diagnosis	
  
	
  
Stage	
  
	
  	
  	
  	
  	
  0	
  (DCIS)	
  
	
  	
  	
  	
  	
  I	
  
	
  	
  	
  	
  	
  IIA	
  
	
  	
  	
  	
  	
  IIB	
  
	
  	
  	
  	
  	
  IIIA	
  
	
  	
  	
  	
  	
  IIIB	
  
	
  	
  	
  	
  	
  IIIC	
  
	
  	
  	
  	
  	
  IV	
  
Grade	
  
	
  	
  	
  	
  	
  Well-‐differentiated	
  
	
  	
  	
  	
  	
  Moderately-‐differentiated	
  
	
  	
  	
  	
  	
  Poorly-‐differentiated	
  

	
  

Mean	
  (SD)	
  
Frequency	
  
	
  
5	
  
25	
  
7	
  
4	
  
10	
  
1	
  
3	
  
4	
  
	
  
8	
  
23	
  
20	
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52.18	
  (13.39)	
  
Percent	
  
	
  
8.5%	
  
42.4%	
  
11.9%	
  
6.8%	
  
16.9%	
  
1.7%	
  
5.1%	
  
6.8%	
  
	
  
13.6%	
  
39.0%	
  
33.9%	
  

	
  
ER	
  Status	
  
	
  	
  	
  	
  	
  Positive	
  
	
  	
  	
  	
  	
  Negative	
  
PR	
  Status	
  
	
  	
  	
  	
  	
  Positive	
  
	
  	
  	
  	
  	
  Negative	
  
Her2Neu	
  Status	
  	
  
	
  	
  	
  	
  	
  Positive	
  
	
  	
  	
  	
  	
  Negative	
  
Triple	
  Negative	
  
	
  	
  	
  	
  	
  Yes	
  
	
  	
  	
  	
  	
  No	
  
Lymphovascular	
  Invasion	
  
	
  	
  	
  	
  	
  Yes	
  
	
  	
  	
  	
  	
  No	
  
Primary,	
  Recurrence,	
  or	
  Metastatic	
  
	
  	
  	
  	
  	
  Primary	
  
	
  	
  	
  	
  	
  Recurrence	
  or	
  Metastatic	
  
Menopausal	
  Status	
  
	
  	
  	
  	
  	
  Pre-‐menopausal	
  
	
  	
  	
  	
  	
  Peri-‐menopausal	
  
	
  	
  	
  	
  	
  Post-‐menopausal	
  
Karnofsky	
  Rating	
  
	
  	
  	
  	
  	
  100%	
  
	
  	
  	
  	
  	
  90%	
  
	
  	
  	
  	
  	
  80%	
  
	
  	
  	
  	
  	
  70%	
  
	
  	
  	
  	
  	
  60%	
  

	
  
41	
  
12	
  
	
  
39	
  
13	
  
	
  
5	
  
42	
  
	
  
8	
  
39	
  
	
  
12	
  
35	
  
	
  
52	
  
	
  	
  7	
  
	
  
23	
  
4	
  
30	
  
	
  
23	
  
20	
  
6	
  
1	
  
2	
  

	
  
77.4%	
  
22.6%	
  
	
  
75.0%	
  
25.0%	
  
	
  
8.5%	
  
89.4%	
  
	
  
17.0%	
  
83.0%	
  
	
  
25.5%	
  
74.55	
  
	
  
88.1%	
  
11.9%	
  
	
  
40.4%	
  
7.0%	
  
52.6%	
  
	
  
44.2%	
  
38.5%	
  
11.5%	
  
1.9%	
  
3.8%	
  

Co-morbid medical disorders. Three participants (5.1%) reported having
recurrent breast cancer and had previously received chemotherapy and/or radiation.
Additionally, one participant (1.7%) reported a history of previous cervical cancer. While
the majority of participants reported no co-morbid medical conditions (n = 29; 49.1%),
the most common co-morbid medical conditions for this sample were high blood pressure
(n = 15; 25.4%) and diabetes (n = 10; 17.0%). Other co-morbid medical conditions
included arthritis/osteoarthritis (n = 3; 5.1%), hypothyroidism (n = 2; 3.4%), and
myocardial infarction (n = 2; 3.4%). One participant (1.7%) reported having scoliosis and
one (1.7%) reported having chronic obstructive pulmonary disease. Additionally, one
participant (1.7%) reported having chronic fatigue syndrome, simple partial seizures, skin
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lesions, and chronic hives; one reported having scleroderma and local positive antinuclear
antibody, which is a diagnostic test for lupus; one reported having supraventricular and
ventricular tachycardia and a heart murmur, in addition to hypertension; and one reported
sarcoidosis and asthma, in addition to hypertension and osteoarthritis.
Medications. Table 3 presents medications used by greater than 10% of
participants. Additionally, less than 10% of participants used medications such as
antihistaminics and sleep medications (n = 5); analgesics, bronchodilators, thyroid
medication, and vitamin supplements (n = 4); anticonvulsants, antitussives,
benzodiazepines, potassium, and urinary antispasmodics (n = 3); adrenergics, antibiotics,
estrogens, and vasodilating agents (n = 2), and anticoagulants, nasal anti-inflammatory
agents, antidiarrheal medications, antirheumatoids, antiviral medications, asthma
medications, cathartics and laxatives, contraceptives, corticosteroids, iron replacements,
insulin, muscle relaxants, prophylaxis, proton pump inhibitor, parathyroid hormones,
respiratory relaxer, sedatives, sulfonylureas, and unclassified therapeutics (n = 1).
Table 3
Medications
	
  
Antihypertensive	
  
NSAIDS	
  (e.g.,	
  aspirin,	
  ibuprofen)	
  
Diuretics	
  
Antilipidemic	
  
Antidiabetics	
  
Antidepressants	
  
Cardiac	
  Medications	
  
Anxiolytics	
  
Gastrointestinal	
  Medications	
  
Opiate	
  Agonists	
  

Frequency	
  
16	
  
16	
  
11	
  
11	
  
10	
  
9	
  
7	
  
6	
  
6	
  
6	
  

Psychosocial Stress Characteristics
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Percent	
  
27.1%	
  
27.1%	
  
18.6%	
  
18.6%	
  
16.9%	
  
15.3%	
  
11.9%	
  
10.2%	
  
10.2%	
  
10.2%	
  

	
  
Ethnicity. Fifty-seven participants provided information regarding ethnicity. The
majority of participants were non-Hispanic (NH) White (n = 33; 57.9%) and African
American (n = 21; 36.8%). Two participants reported their ethnicity as Native American
(3.5%), and one participant reported her ethnicity as Asian American (1.8%). As
previously reported, analyses excluded participants who reported an ethnicity other than
NH White or African American out of respect for potential cultural/ethnic differences on
outcome variables. Additionally, the small sample size would not allow statistical
analyses to explore ethnic differences for those who reported their ethnicity as Native
American or Asian American.
Neighborhood stress. Census tract data was available for 47 participants.
Neighborhood stress was measured with four variables, the percentage of households
below the poverty level within the census tract, the median household income in the
census tract, the percentage of single-parent homes within the census tract, and the
percentage of renter-occupied homes within the census tract. The 47 participants lived in
a total of 41 different census tracts. Within the census tracts, the average (SD) percentage
of households below the poverty level was 16.66 (12.71), the average (SD) median
household income was $50,868.72 ($23,617.78), the average (SD) percentage of singleparent homes was 39.84 (24.82), and the average (SD) percentage of renter-occupied
homes was 31.16 (19.25).
Cancer-related stress. The Impact of Events Scale (IES) total distress score was
used to measure participants’ current amount of distress related to their cancer. Fifty-six
participants provided IES data. During data cleaning, an error with the IES wording was
identified. For the second half of our participants, the wording on the IES had been
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changed, such that the Likert scale read “not at all, rarely, sometimes, and never” rather
than the appropriate “not at all, rarely, sometimes, and often.” It was determined that one
participant who answered endorsed a “3” truly meant “never” and did not mean “often.”
By viewing a scatterplot of IES baseline and IES daily comparison scores that one
participant was an outlier. We then reviewed her IES baseline raw data with her IES
intrusions daily raw data. It was determined that her baseline raw data did not match the
daily raw data based on the IES daily scores of mostly zero. Based on this, we changed
her “threes” to “zeros” on the IES baseline raw data to better match her apparent intended
responses. Therefore, that participant’s data was edited accordingly, and the total score
was then calculated with this edited data.
The average (SD) total distress score was 28.38 (15.37), which suggests the
presence of symptoms of both intrusive thoughts and avoidance of thoughts related to a
cancer diagnosis. Scores of 19 or greater are worthy of additional investigation and scores
35 or greater likely represents a diagnosis of PTSD (Horowitz et al., 1979). In this
sample, 43 (76.8%) participants scored 19 or greater and 26 (46.4%) participants scored
35 or greater on the IES.
Physiological Disruption Characteristics
Circadian disruption. Descriptive statistics for wrist-worn actigraphy variables
are presented in Table 4. Of the 57 participants, one participant was provided with a
watch that was initialized in the wrong recording mode, which meant that the data that
was returned was unusable for the calculations. One participant’s actiwatch battery failed
and there was not time to collect replacement data before surgical treatment. Therefore,
the resulting sample size for actigraphy data was 55. The average (SD) rest/activity
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rhythm coefficient of .28 (.17) is indicative of a relatively rhythmic circadian activity
pattern in this sample. Additionally, percentages for nighttime restfulness (97.38%) and
daytime sedentariness (6.03%) show that many of the sample experienced restful
evenings and a good amount of activity during the day, which are indicative of high
circadian rhythmicity.
Table 4
Actigraphy Descriptive Statistics
Rest/activity rhythm
Nighttime restfulness, %age
Daytime sedentariness, %age

N
55
55
55

Mean (SD)
.28 (.17)
97.38 (3.26)
6.03 (5.41)

Endocrine disruption. Descriptive statistics for diurnal cortisol variables are
presented in Table 5. Note that the CAR slope is more vulnerable to missing data than the
other variables; therefore, the sample size for CAR slope is lower than the sample size for
diurnal cortisol slope and diurnal cortisol mean. Average (SD) raw cortisol for the threeday collection was 0.25 (.11). Average and 95% confidence intervals for raw cortisol
values for each point of data collection point are presented in Figure 8, which appears to
resemble a healthy diurnal cortisol slope, with a peak approximately 30 minutes after
awakening and a nadir at bedtime.
Table 5
Diurnal Cortisol Descriptive Statistics
CAR Slope, log(µg/dL)/hr
Diurnal Cortisol slope, log(µg/dL)/hr
Diurnal Mean Cortisol, log(µg/dL)

	
  

N
45
57
57

72

Mean (SD)
.10 (.47)
-.07 (.09)
-1.89 (.48)

	
  

Man & 95% CI Salivary Cortisol, µg/
dL

0.5

0.4

0.3

0.2

0.1

0

Waking

Waking+30

Afternoon

Bedtime

Figure 8. Mean with 95% confidence interval diurnal salivary cortisol values over the
three-day data collection period.
Immune function. Descriptive statistics for serum cytokine levels are provided in
Table 6. Serum cytokines were grouped into three factors using EFA (previously
described, Cash et al., 2015). Factor 1 includes VEGF, MMP-9, and TGF-β, factor 2
includes IL-1β, IL-6R, TNF-α, and MCP-1, and factor 3 includes IL-6, IL-12, and IFN-γ.
Table 6
Immune Function Descriptive Statistics
Factor 1
VEGF, pg/mL
MMP-9, pg/mL
TGF-β, pg/mL
Factor 2
IL-1β, pg/mL
IL-6R, pg/mL
TNF-α, pg/mL
MCP-1, pg/mL
Factor 3
IL-6, pg/mL
	
  

N

Mean (SD)

50
50
50

383.99 (228.86)
28.84 (18.23)
2.67 (1.04)

50
50
50
50

0.52 (2.05)
6242.39 (1687.03)
24.30 (115.03)
148.19 (60.00)

50

19.19 (120.41)
73

	
  
IL-12, pg/mL
IFN-γ, pg/mL

50
50

17.95 (31.28)
1.16 (1.07)

Progression-Free Survival
Data on progression-free survival was obtained from KCR at a median of seven
years post-enrollment and was available for 53 participants. Of the 53 participants, 30.2%
(n = 16) had experienced a recurrence or had passed away. Six women had recurrent
disease, but had not passed away. Ten participants had passed away, of which eight had
recurrent disease. Descriptive statistics for progression-free survival from date of
diagnosis or date of data collection are provided in Table 7.
Table 7
Progression-Free Survival Descriptive Statistics

From Date of Diagnosis
From Date of Background Completion
From Date of Actigraphy Collection
From Date of Cortisol Collection
From Date of Blood Draw

N
49
49
49
52
45

Days
Years
Mean (SD)
2103.63 (823.84) 5.76 (2.26)
2000.33 (799.90) 5.48 (2.19)
2081.59 (810.58) 5.70 (2.22)
2030.46 (795.48) 5.56 (2.18)
1984.13 (789.22) 5.43 (2.16)

Principal Components Analysis of Neighborhood Stress
A principal components analysis (PCA) was performed with orthogonal rotation
(varimax) to determine the degree to which the four variables of neighborhood stress that
were collected (i.e., percentage of households below the poverty line, median household
income, percentage of single-parent homes, and percentage of renter-occupied housing in
the neighborhood) varied together. Given that the data were skewed and on different
scales (i.e., percentages and median values), the data were transformed and standardized
to address each concern, respectively.
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The Kaiser-Meyer-Olkin (KMO) statistic, a measure of sampling adequacy, was
.852, which is in the “great” range and is indicative that the sample size is adequate and
the PCA will yield distinct and reliable factors (Field, 2009). Additionally, all KMO
values for individual items were greater than .82, which is well above the acceptable limit
of .5 (Field, 2009). Bartlett’s test of sphericity indicated that correlations between items
were sufficiently large enough to run PCA, χ2 (6) = 166.56, p < .001 (Field, 2009). One
variable had an eigenvalue greater than one, and through examination of the scree plot,
there was one point of inflection, which justify that the four variables in the PCA cluster
to form one factor (Field, 2009), which represents neighborhood stress. Factor scores for
each participant were obtained using the regression method in SPSS, and these scores
were used as the independent variable in analyses. Table 8 provides the anti-image
correlation matrix for the PCA. Table 9 provides the eigenvalues and total variance
explained by the PCA. Table 10 provides the factor loadings.
Table 8
Anti-Image Correlation Matrix
% Households
Below Poverty
Level
.828*

Median
Household
Income
.503

% Households
Below Poverty
Level
Median
-.832*
Household
Income
% Single-Parent --Homes
% Renter--Occupied
Homes
* Measures of Sampling Adequacy
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% SingleParent Homes
-.136

% RenterOccupied
Homes
-.384

.372

.121

.878*

-.330

--

.875*

	
  
Table 9
Total Variance Explained
Initial Eigenvalues
Component

Total
3.423

% of
Variance
85.576

Cumulative
%
85.576

% Households
Below Poverty
Level
Median Household
Income
% Single-Parent
Homes
% RenterOccupied Homes

0.225

5.614

91.190

0.220

5.504

96.694

0.132

3.306

100.000

Extraction Sums of Squared
Loadings
Total
% of
Cumulative
Variance
%
3.423 85.576
85.576

Table 10
Factor Loadings
Factor
1

Variables Included
% Households Below Poverty Level
Median Household Income
% Single-Parent Homes
% Renter-Occupied Homes

Factor Loading
.936
-.934
.915
.915

	
  
Primary Analyses
For tests of hypotheses, significant results are presented in tables. When multiple
independent variables were entered to test the same outcome (e.g., survival analyses with
three actigraphy measures all relating to survival), data are presented from step 1 of only
one model. Effect sizes for each step of the model are denoted by R2 and ΔR2 values
presented in each table. Full result tables are presented in Appendix C.
Hypothesis 1A, 1B, and 1C. Ethnicity, neighborhood stress, and cancerrelated stress will be significantly and positively correlated with one another (Figure
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2). Ethnicity and neighborhood stress were highly correlated, r(43) = .615, p < .001. NH
White ethnicity was statistically significantly correlated with lower neighborhood stress,
whereas African American ethnicity was statistically significantly correlated with greater
neighborhood stress. Neither ethnicity nor neighborhood stress was significantly
correlated with cancer-related stress. The correlation matrix is presented in Table 11.
Table 11
Spearman’s rho correlation matrix for hypothesis 1.
1
2
3
1. Ethnicity
-.615*
-.066
2. Neighborhood
--.172
stress
3. Cancer-related
---stress
* p < .001
	
  
Hypothesis 2. Tests of hypotheses 2 will explore associations of psychosocial
stress (i.e., ethnicity, neighborhood stress, and cancer-related distress) with
physiological disruption (i.e., circadian, endocrine, and immune; Figure 1, Arrow
A), associations of psychosocial stress and medical outcomes of cancer (i.e.,
progression-free survival; Figure 1, Arrow B), and associations of physiological
stress and medical outcomes of cancer (Figure 1, Arrow C).
Ethnicity as a predictor. Hypothesis 2A.1. African American ethnicity will be
independently associated with greater circadian disruption, endocrine disruption, and
immune disruption.
Circadian outcomes (Figure 3). In the model of ethnicity predicting rest/activity
rhythms, control variables as a group (ΔR2 = .223; F(3, 39) = 3.728, p = .019) were
significant predictors in the model and income added significant predictive power to the
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model (partial r = .442; Figure 9). The overall model was not significant. Patients with
lower income had less rhythmic circadian patterns of activity.
In the model of ethnicity predicting nighttime restfulness, control variables were
not significant predictors of nighttime restfulness as a group, nor were they significant
individually. The overall model was not significant.
Control variables as a group (ΔR2 = .185; F(3, 39) = 2.942, p = .045) were
significant predictors in the model of ethnicity predicting daytime sedentariness, and
income added significant predictive power to the model (partial r = -.378; Figure 9). The
overall model was not significant. Patients with lower income had greater circadian
disruption.
Endocrine outcomes (Figure 3). In the models of ethnicity predicting endocrine
disruption, control variables were not significant as a group, nor were they significant
individually. Additionally, ethnicity did not emerge as significantly associated with
variables of endocrine disruption.
Immune outcomes (Figure 3). In both the model of ethnicity predicting immune
factor 1 and the model predicting immune factor 2, control variables were not significant
as a group, nor were they significant individually. The overall models for factor 1 and
factor 2 were not significant.
In the model of ethnicity predicting immune factor 3 (IL-6; IL-12; IFN-γ), control
variables as a group (ΔR2 = .342; F(3, 32) = 5.546, p = .004) were significant predictors.
Additionally, age added significant predictive power to the model (partial r = -.566;
Figure 9). The overall model was not significant. Younger patients had greater secretion
of inflammatory/TH1-type cytokines (Factor 3: IL-6; IL-12; IFN-γ).
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Figure 9. Significant associations with control variables for associations of
ethnicity with physiological disruption.

Neighborhood stress as a predictor. Hypothesis 2A.2. Neighborhood stress will
be independently associated with greater circadian disruption, endocrine disruption, and
immune disruption.
Circadian outcomes (Figure 4). Control variables as a group (ΔR2 = .281; F(3, 36)
= 4.680, p = .007) were significant predictors in the model neighborhood stress predicting
rest/activity rhythms and income added significant predictive power (partial r - .503;
Figure 11). However, the overall model was not significant. Patients with lower income
had less rhythmic circadian pattern of activity.
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In the model of neighborhood stress predicting nighttime restfulness, control
variables were not significant as a group, nor were they significant individually. The
overall model was not significant
In the model of neighborhood stress predicting daytime sedentariness, control
variables as a group were not significant. Income added significant predictive power to
the model in predicting daytime sedentariness (partial r = -.361; Figure 11). The overall
model was not significant. Patients with lower income had greater circadian disruption.
Endocrine outcomes (Figure 4). Control variables were not significant as a group,
nor were they significant individually in the model of neighborhood stress predicting
CAR slope. The overall model was not significant.
In the model testing relationships of control variables and neighborhood stress
with diurnal cortisol slope, control variables were not significant as a group. However,
income added significant predictive power to the model (partial r = -.365; Figure 11). The
overall model was not significant. Patients with lower income had flatter slopes, which
are indicative of a less healthy pattern.
The overall model of the association of neighborhood stress with diurnal cortisol
mean was significant (ΔR2 = .246; F(4, 36) = 4.557, p = .001; Figure 10); however,
control variables as a group were not significant, nor were they significant individually.
Neighborhood stress was noted to be a significant predictor in the model testing diurnal
cortisol mean (partial r = .520), demonstrating that patients with greater neighborhood
stress had greater overall cortisol secretion, which is indicative of a less healthy pattern of
cortisol secretion. Significant results are presented in Table 12.
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Figure 10. Significant association between neighborhood stress and endocrine
disruption (i.e., diurnal mean).

Table 12
Significant results for hypothesis 2A.2: Hierarchical regression analyses entered
neighborhood stress as a predictor of endocrine disruption.
Variable
Diurnal cortisol mean
Step 1
Age
Stage
Income
Step 2
Neighborhood stress
* p < .05

	
  

N
41

B

SE B

.011
.027
-.022

.006
.038
.046

.290

.079

81

β

R2

ΔR2

.090

.090

.314

.336

.246

.001*

p of ΔR2

.277
.113
-.076
.537

	
  
Immune outcomes (Figure 4). In both the model of neighborhood stress predicting
immune factor 1 and the model predicting immune factor 2, control variables were not
significant as a group, nor were any of them significant individually. The overall models
for factor 1 and factor 2 were not significant.
In the model of neighborhood stress predicting immune factor 3 (IL-6; IL-12;
IFN-γ), control variables as a group (ΔR2 = .438; F(3, 30) = 7.799, p = .001) were
significant predictors in the model. Additionally, age (partial r = -.622; Figure 10) and
stage (partial r = -.396; Figure 11) added significant predictive power to the model
predicting immune factor 3 (IL-6; IL-12; IFN-γ). However, the overall model was not
significant. Younger patients and patients who had lower stage disease had greater
section of inflammatory/TH1-type cytokines (Factor 3: IL-6; IL-12; IFN-γ).

Figure 11. Significant associations with control variables for associations of
neighborhood stress with physiological disruption.
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Cancer-related stress as a predictor. Hypothesis 2A.3. Cancer-related stress will
be independently associated with greater circadian disruption, endocrine disruption, and
immune disruption.
Circadian outcomes (Figure 5). Control variables as a group (ΔR2 = .236; F(3, 41)
= 4.225, p = .011) were significant predictors in the model of cancer-related stress
predicting rest/activity rhythms. Income added significant predictive power to the model
in in predicting rest/activity rhythms (partial r = .465; Figure 14). The overall model was
not significant. Patients with lower income had less rhythmic circadian pattern of activity.
In the model predicting nighttime restfulness, control variables were not
significant as a group, nor were they significant individually. The overall model was also
not significant.
In the model predicting daytime sedentariness, control variables as a group were
not significant; however, income added significant predictive power to the model (partial
r = -.370; Figure 14). The overall model was not significant. Patients with lower income
had greater circadian.
Endocrine outcomes (Figure 5). In the model of cancer-related stress predicting
CAR slope, control variables were not significant as a group, nor were they significant
individually. Additionally, the overall model was not significant.
The association of cancer-related stress with diurnal cortisol slope was significant
in the overall model (ΔR2 = .084; F(1, 42) = 4.182, p = .047; Figure 12). Control variables
were not significant as a group, nor were they significant individually. Cancer-related
stress was noted to be a significant predictor in the model testing diurnal cortisol slope
(partial r = -.301; Figure 12), demonstrating that patients with greater cancer-related
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stress had steeper slopes, which is indicative of a healthier pattern. For descriptive
purposes, mean and 95% confidence interval raw cortisol values are shown across three
days of sample collection. IES summary scores were split at median IES (Figure 13).

Figure 12. Significant association between cancer-related stress and
endocrine disruption (i.e., diurnal slope).
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Figure 13. Mean and 95% confidence interval raw diurnal cortisol
values with median split IES summary scores.
In the model of cancer-related stress predicting diurnal cortisol mean, control
variables were not significant as a group, nor were they significant individually. The
overall model was not significant. Significant results are presented in Table 13.
Table 13
Summary of results for hypothesis 2A.3: Hierarchical regression analyses entered cancerrelated stress as a predictor of endocrine disruption.
Variable
Diurnal cortisol slope
Step 1
Age
Stage
Income
Step 2
Cancer-related stress
* p < .05

	
  

N
47

B

SE B

-.001
-.002
-.013

.001
.006
.008

-.002

.001

85

β

R2

ΔR2

.071

.071

.358

.156

.084

.047*

p of ΔR2

-.099
-.053
-.258
-.292

	
  
	
  
Immune outcomes (Figure 5). In both the model of cancer-related stress predicting
immune factor 1 and the model predicting immune factor 2, control variables were not
significant as a group, nor were they significant individually. The overall models for
factor 1 and factor 2 were not significant.
Control variables as a group (ΔR2 = .288; F(3, 35) = 4.170, p = .007) were
significant predictors in the model of cancer-related stress predicting immune factor 3
(IL-6; IL-12; IFN-γ). Additionally, age (partial r = -.509; Figure 14) added significant
predictive power to the model. However, the overall model was not significant. Younger
patients had greater secretion of inflammatory/TH1-type cytokines (Factor 3: IL-6; IL-12;
IFN-γ).

Figure 14. Significant associations with control variables for associations of
cancer-related stress with physiological disruption.
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Ethnicity as a predictor of progression-free survival (Figure 6, Arrow 1).
Hypothesis 2B1. African American ethnicity will be independently associated with
shorter breast cancer progression-free survival.
Ethnicity did not emerge as a significant predictor of progression-free survival
measured from either date of diagnosis or date of study entry.
Neighborhood socioeconomic stress as a predictor of progression-free survival
(Figure 6, Arrow 2). Hypothesis 2B.2. Neighborhood stress will be independently
associated with shorter breast cancer progression-free survival.
Neighborhood stress did not emerge as a significant predictor of progression-free
survival measured from either date of diagnosis or date of study entry.
Cancer-related stress as a predictor of progression-free survival (Figure 6,
Arrow 3). Hypothesis 2B.3. Cancer-related stress will be independently associated with
shorter breast cancer progression-free survival.
Cancer-related stress did not emerge as a significant predictor of progression-free
survival from either date of diagnosis or date of stress assessment.
Circadian disruption variables as predictors of progression-free survival
(Figure 7, Arrow 1). Hypothesis 2C.1. Circadian disruption will be independently
associated with shorter breast cancer progression-free survival.
No circadian disruption variables (i.e., rest/activity rhythms, nighttime restfulness,
and daytime sedentariness) emerged as significant predictors of progression-free survival
from either date of diagnosis or date of first actigraphy assessment.
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Endocrine disruption variables as predictors of progression-free survival
(Figure 7, Arrow 2). Hypothesis 2C.2. Endocrine disruption will be independently
associated with shorter breast cancer progression-free survival.
No endocrine disruption variables (i.e., CAR slope, diurnal cortisol slope, and
diurnal cortisol mean) emerged as significant predictors of progression-free survival from
either date of diagnosis or date of first cortisol collection.
Immune disruption variables as predictors of progression-free survival (Figure
7, Arrow 3). Hypothesis 2C.3. Immune disruption will be independently associated with
shorter breast cancer progression-free survival.
No immune factors (i.e., Factor 1, Factor 2, and Factor 3) emerged as significant
predictors of progression-free survival from either date of diagnosis or date of blood
draw.
Post hoc analyses.
In tests of hypothesis 2A.3, cancer-related stress was related to diurnal cortisol
slope, such that participants who endorsed greater cancer-related stress had steeper
cortisol slopes, which are indicative of a healthy cortisol pattern. Given that these
findings are in the opposite direction than hypothesized, post hoc analyses were
conducted to gain a better understanding of this relationship. Upon examining subscales
of the IES, the measure of cancer-related stress, avoidance (partial r = -.410), but not
intrusions were significantly related to diurnal cortisol slope. For descriptive purposes,
mean and 95% confidence interval raw cortisol values are shown across 3 days of sample
collection. IES avoidance scores were split at the median (Figure 15). Therefore, patients
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who endorsed greater levels of cancer-related avoidance had steeper, healthier diurnal
cortisol slopes. Post hoc analyses results are presented in Table 14.

Figure 15. Mean and 95% confidence interval raw diurnal cortisol
values with median split IES avoidance scores.
Table 14
Summary of results for post hoc analyses: Hierarchical regression analyses entered
cancer-related stress subscales as a predictor of diurnal cortisol slope.
Variable
Diurnal Cortisol Slope
Step 1
Age
Stage
Income
Step 2
Cancer-related stress:
Avoidance
* p < .05
	
  

	
  

N
48

B

SE B

β

-.001
-.003
-.015

.001
.006
.008

-.124
-.077
-.283

-.004

.001

-.399

89

R2

ΔR2

.091

.091

.234

.244

.153

.005*

p of ΔR2

	
  
Summary of Results
Primary analyses showed that ethnicity and neighborhood stress were statistically
significantly associated, such that NH White patients had lower neighborhood stress and
African American patients had greater neighborhood stress, which includes the
percentage of households below the poverty line, median household income, percentage
of single-parent homes, and percentage of renter-occupied housing in the neighborhood.
This supports the hypothesis that ethnicity and neighborhood stress would be correlated,
as both can be viewed measures of psychosocial stress. However, cancer-related stress
was not significantly correlated with either ethnicity or neighborhood stress.
For associations of ethnicity with circadian variables, the control variables (i.e.,
age, stage, and income) as a group were significant predictors of rest/activity rhythms (p
= .019) and daytime sedentariness (p = .045), with effect sizes of .223 and .185,
respectively. Control variables as a group were not significant predictors for associations
of ethnicity with endocrine variables. For associations of ethnicity with immune
variables, the control variables (i.e., age, stage, and income) as a group were significant
predictors of Factor 3 (p = .004) with an effect size of .342.
For associations of neighborhood stress with circadian variables, the control
variables (i.e., age, stage, and income) as a group were significant predictors of
rest/activity rhythms (p = .007) with an effect size of .281. In analyses of relationships
between neighborhood stress and endocrine disruption, control variables as a group were
not significant predictors. Control variables as a group were significant predictors of
Factor 3 (p = .001) with an effect size of .438 in analyses of associations between
neighborhood stress and immune disruption. Additionally, neighborhood stress was
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statistically significantly related to diurnal cortisol mean, such that patients with greater
neighborhood stress had greater overall cortisol secretion, which is indicative of a less
healthy pattern of cortisol secretion.
For associations of cancer-related stress with circadian variables, the control
variables (i.e., age, stage, and income) as a group were significant predictors of
rest/activity rhythms (p = .011) with an effect size of .236; however, the control variables
as a group were not significant predictors for associations of cancer-related stress with
endocrine variables. In analyses testing associations of cancer-related stress with immune
variables, control variables as a group were significant predictors of Factor 3 (p = .007)
with an effect size of .288. Cancer-related stress was statistically significantly related to
diurnal cortisol slope, such that those reporting greater cancer-related stress had steeper
diurnal cortisol slopes, which is indicative of a healthier cortisol profile. Post hoc
analyses revealed that symptoms of avoidance, but not intrusions, were driving the
relationships between cancer-related stress and diurnal cortisol slope, such that patients
who endorsed greater avoidance had steeper slopes.
Analyses failed to support hypotheses that psychosocial stress factors are
associated with variables of circadian disruption and immune disruption. However, two
results were not statistically significant, but are worthy of discussion. The relationship
between ethnicity and immune factor 2 (IL-1β, IL-6R, TNF-α, MCP-1) was not
significant (p = .085), but the direction of the relationship indicates African American
participants had lower levels of factor 1 immune parameters than NH White participants.
The relationship between neighborhood stress and immune factor 1 (VEGF, MMP-9,
TFG- β) was not significant (p = .066); however, the relationship between the variables
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indicates that participants with greater neighborhood stress had lower levels of immune
factor 1 parameters.
Interestingly, income was a significant control variable for the circadian
disruption variables rest/activity rhythms and daytime sedentariness. Participants with
lower income had less rhythmic circadian patterns of activity and greater daytime
sedentary behavior, both of which are indicative of circadian disruption. Additionally,
age was a significant control variable for immune factor 3 (IL-6, IL-12, IFN-γ). Younger
participants had greater secretion of these immune parameters. In analyses exploring the
relationship between neighborhood stress and diurnal cortisol slope, income arose as a
significant control variable, such that participants with lower income had flatter cortisol
slopes, indicative of a less healthy cortisol pattern.
Analyses failed to support the hypotheses that psychosocial stress factors and
physiological disruption would be predictive of progression-free survival.
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DISCUSSION

This exploratory study examined the effects of psychosocial stress on
physiological disruption in presurgical breast cancer patients. Additionally, the predictive
value of psychosocial stress and physiological disruption on progression-free survival
was also explored. As expected, ethnicity and neighborhood stress were correlated, such
that African American participants had greater neighborhood stress. Therefore, it appears
that the African American women in our sample are more likely to live in a neighborhood
that can be viewed as socioeconomically stressful (i.e., a higher percentage of households
below the poverty line, lower median household income, higher percentage of singleparent homes, and higher percentage of renter-occupied housing). Associations of
ethnicity and neighborhood stress with cancer-related stress did not emerge.
Ethnicity was not related to any measure of physiological disruption (i.e.,
circadian disruption, endocrine disruption, and immune disruption). Although no
significant associations were observed in these analyses, these associations should
continue to be explored within a cancer context, as it is possible that physiological
disruption may help to explain ethnic cancer disparities.
Participants experiencing greater neighborhood stress had greater overall diurnal
cortisol mean secretion. This suggests that stress associated with the socioeconomic
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status of one’s neighborhood may have an adverse impact on physiology. It is possible
that the likely chronic nature of neighborhood stress alters physiology, specifically
cortisol secretion. Additional analyses are warranted to explore how neighborhood stress
impacts physiological disruption, particularly measures of chronic stress. Neighborhood
stress was not associated with any other measure of physiological disruption.
Women experiencing greater cancer-related stress in our sample had steeper
diurnal cortisol slopes, which can be indicative of a healthier cortisol profile. This finding
is interesting in that it is in the opposite direction than anticipated. Post hoc analyses
showed that avoidance, but not intrusions, were significantly associated with diurnal
cortisol slope. Patients who endorsed greater avoidance had steeper slopes, which may
indicate that during the presurgical period, avoidance may be a healthy way of coping
through this acutely stressful period. Therefore, it is possible that in this sample of breast
cancer patients who are presurgical, avoidance is serving as a buffer to stress, rather than
a detriment, which may lead to a healthier diurnal cortisol pattern. Continued analysis is
needed to determine the role of cancer-related stress, particularly avoidance, on
physiological disruption during the presurgical phase of breast cancer treatment.
Cancer-related stress was not associated with measures of circadian disruption,
other measures of endocrine disruption (i.e., CAR slope or mean diurnal cortisol), or
measures of immune disruption.
In analyses exploring associations between measures of psychosocial stress and
physiological disruption, patients with lower income had less rhythmic circadian patterns
of activity (i.e., greater circadian disruption). Patients with lower income had less healthy
cortisol slope profiles (i.e., flatter slopes). Therefore, it is likely that individual
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socioeconomic status may serve as a source of stress in our sample, and in turn, may
influence circadian and endocrine physiology.
Additionally, greater secretion of inflammatory/TH1-type cytokines (i.e., IL-6, IL12, IFN-γ) was observed in younger patients for analyses testing relationships between
psychosocial stress and physiological disruption. It is possible that age may affect
immune function in women with breast cancer. Research would benefit from exploration
of potential differences in immune function between younger and older breast cancer
patients, which may aid in the understanding of the difference in the epidemiology and
prognosis of breast cancer in younger women.
Our analyses of psychosocial and physiological variables as prognostic indicators
of progression-free survival produced no significant findings.
A fair amount of cancer research has focused on the relationships between
psychosocial stress, physiological disruption, and disease progression; however, life
context (e.g., ethnicity and neighborhood-related stressors) has rarely been explored
within this framework. These novel data provide an opportunity to explore multiple types
of psychosocial stress (i.e., ethnicity, neighborhood stress, and cancer-related stress) and
their relationship with physiological disruption measures (i.e., circadian, endocrine, and
immune disruption). By exploring these varying facets of stress, one can begin to
understand which domains may be most salient in presurgical breast cancer patients and
can provide suggestions for medical and psychological clinical interventions.
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Associations Between Measures of Psychosocial Stress: Ethnicity was correlated
with neighborhood stress, but not cancer-related stress. Neighborhood stress was
not correlated with cancer-related stress (Figure 2).
We conceptualized neighborhood stress as a composite of four variables related to
socioeconomic status (i.e., percentage of households below the poverty line, median
household income, percentage of single-parent homes, and percentage of renter-occupied
housing in the neighborhood). Thus, we expected associations of our neighborhood stress
measure with indicators of poverty. As expected, this study revealed that, in this sample
of presurgical breast cancer patients, ethnicity was related to neighborhood stress. These
findings are consistent with previous literature that indicates that, in the United States,
ethnic minorities live in areas with concentrated poverty (Jargowsky & Yang, 2006;
Lichter, Parisi, & Taquino, 2012). Additionally, African Americans have higher rates of
individuals of living in areas of concentrated poverty compared to NH Whites (Lichter et
al., 2012).
Neither ethnicity nor neighborhood stress was associated with cancer-related
stress. These findings are inconsistent with previous literature regarding cancer-related
stress symptoms across ethnicities. In a study of women who had been diagnosed with
breast cancer in the prior two to three months, African American women were more
likely than White women to endorse traumatic symptoms related to the cancer diagnosis
and met criteria for PTSD (Vin-Raviv et al., 2013). A large proportion of participants in
the study had completed surgery (i.e., lumpectomy or mastectomy) at baseline (VinRaviv et al., 2013). Therefore, it is possible that the discrepancy in the timing of the
administration of the cancer-related stress assessment in our study compared to the study
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by Vin-Raviv and colleagues (2013) may explain the differences in findings. This may be
due to African Americans experiencing differences in treatment and expectations for
recovery. African Americans are often diagnosed with more adverse cancer pathology
(Middleton et al., 2003), which is likely to need more intensive intervention and could
make recovery more difficult. African American breast cancer patients have reported
having a lack of information regarding treatment protocols and expectations regarding
side effects (Lackey, Fates, & Brown, 2001), which could increase stress following
surgery. Furthermore, African Americans often rely on support from extended family and
friends to cope; however, a sample of African American women with breast cancer
reported that it was difficult to receive the support they needed due to their families own
difficulties with coping (Ashing-Giwa et al., 2004). Furthermore, patients with colorectal
cancer reported feeling as though their cancer was a burden on family, which was related
to lower perception of physical health improvement (Kim, Shaffer, Rocha-Lima, Milton,
& Carver, 2016). Therefore, a lack of adequate support, or feeling as though one is a
burden on family may contribute to increases in stress following the receipt of cancer
treatment.
We expected to see associations of cancer-related stress with ethnicity and
neighborhood stress. This hypothesis was based on the assumption that African
Americans and those living in neighborhoods with lower socioeconomic resources would
be more disadvantaged, possibly with less access to healthcare, which would translate to
greater stress regarding their diagnosis. Lazarus and Folkman’s (1984) theoretical model
of stress and coping may help in understanding discrepancies between our presurgical
breast cancer sample from other post-surgical samples. Women face new cancer-related
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challenges throughout the cancer trajectory (e.g., surgery, treatment, recovery,
negotiating the medical system, fear of recurrence, and mortality). It is possible that they
may experience an imbalance between stress and their resources to cope with demands,
and that this imbalance may be greater after beginning treatment. Therefore, our lack of
associations may be due to the assessment period being prior to initiation of any
treatment interventions (e.g., surgery). It may be that over time, as the participants in the
study adjust to the treatment and associated physical, social, and emotional changes,
cancer-related stress may change. It is possible that ethnicity and neighborhood stress
may play a role in those changes, particularly when taking into consideration
disadvantages seen in ethnic minorities and those living in neighborhoods with high
stress (e.g., fewer resources). However, in this study, women’s ethnicity and current
neighborhood status appeared unrelated to their perception of stress related to cancer.
Associations Between Psychosocial Stress and Physiological Disruption
African American ethnicity was not related to circadian disruption,
endocrine disruption, or immune disruption (Figure 3). Ethnicity was not
significantly related to measures of physiological disruption in this study. No research
has explored ethnic differences in rest/activity rhythms. Given that we have exhausted the
options in the literature that applies to this study, we compare our sample to those
exploring ethnic differences in sleep, which is likely correlated with rest/activity rhythms.
Sleep research has shown ethnic differences in sleep architecture (Rao et al., 1999), total
sleep time (Hale & Do, 2007; Lemola et al., 2013; Profant et al., 2002), sleep efficiency
(Lemola et al., 2013); daytime sleepiness (Ancoli-Israel et al., 1995; Chen et al., 2015);
and difficulties falling (Ancoli-Israel et al., 1995; Jean-Louis et al., 2000) and staying
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asleep (Jean-Louis et al., 2000). Given these studies explored sleep, which is
fundamentally different than rest/activity rhythms, this may explain why we did not
observe a relationship with ethnicity, while other studies assessing sleep did.
Furthermore, it does not appear that there are published studies that have explored
ethnicity and either sleep or rest/activity relationships in cancer samples. It is possible
that within this sample of breast cancer patients, circadian rhythms may not be influenced
by ethnicity. This could be due to additional factors seen in patients with cancer,
particularly those with active tumors, which explain greater variance in circadian
disruption than ethnicity.
The lack of a significant relationship between ethnicity and endocrine disruption
is inconsistent with previous literature that has shown salivary cortisol secretion and
diurnal cortisol slope dysregulation in African Americans, but not NH Whites.
Specifically, among healthy young to middle-aged women, African Americans had flatter
diurnal cortisol slopes (Cohen et al., 2006); this relationship was also observed in middleaged to older adult women (McCallum et al., 2006). Hispanic middle to older-aged
women had significantly flatter slopes compared to NH Whites in a sample consisting of
caregivers and non-caregivers (Gallagher-Thompson et al., 2006). In a sample of
pregnant women, African Americans had flatter cortisol slopes than their Hispanic
counterparts (Suglia et al., 2010). Among healthy adults, African Americans had flatter
slopes and lower waking cortisol levels (Hajat et al., 2010). Similar findings have been
observed in African American and Hispanic adolescents (DeSantis et al., 2007).
However, research did not find ethnic differences in endocrine disruption in a populationbased study of middle-aged men and women utilizing urinary cortisol (Masi et al., 2004).
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Inconsistences with prior research may be related to differences in measurement or
analysis of data (e.g., cortisol slope calculation).
Within our sample, the lack of an association between ethnicity and endocrine
disruption could be due to other factors that may account for endocrine disruption. For
example, previous research showing ethnic differences in overall cortisol secretion
indicated that perceived stress may explain ethnic differences (Bennett et al., 2004).
Additionally, in a community-based sample of adult men and women, African American
and Hispanic/Latino participants had flatter slopes associated with increased psychosocial
stress (DeSantis, Adam, Hawkley, Kudielka, & Cacioppo, 2015). It is possible that the
perception of stress related to ethnicity (e.g., racial/ethnic discrimination) may be related
to endocrine disruption, and only measuring ethnicity may not fully capture this effect.
Limited research has explored ethnic differences in immune disruption and has
shown that, in healthy adults, lower levels of IL-8 and G-CSF (Mayr et al., 2007) and
higher levels of IL-6 and CRP have been observed in African Americans compared to
NH Whites (Stowe et al., 2010). We did not observe ethnic differences in immune
variables. The inconsistences with prior research may be due to a number of different
factors, such as methodological differences, differences in blood collection (i.e., serum
vs. plasma), and differences in collection time (Mayr et al., 2007; Stowe et al., 2010).
Additionally, one study’s sample was only men (Mayr et al., 2007), which may also
explain the differences between their findings and this study. Indeed, there are sex
differences in immune function (Nakamura et al., 2000; Oertelt-Prigione, 2012). Other
factors may better explain differences in immune functioning than ethnicity. For
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example, it is possible that the ethnic differences observed in plasma CRP may be driven
by body mass index and obesity (Stowe et al., 2010).
In this study, ethnicity is conceptualized as a potential psychosocial stressor. The
lack of associations observed between ethnicity and physiological disruption may
indicate that factors related to ethnicity (e.g., racial/ethnic discrimination) may better
capture ethnicity as a stressor. Ethnicity-related factors, such as racial/ethnic
discrimination can likely be conceptualized as a chronic stressor. Among adolescents,
increased perceived discrimination was associated with elevated cortisol levels
throughout the day (Huynh, Guan, Almeida, McCreath, & Fuligni, 2016) and ethnicity
moderated the relationship between perceptions of discrimination and diurnal cortisol
slope (Zeiders, Hoyt, & Adam). Additionally, African American young women reporting
one or two discriminatory experiences had higher levels of CRP than those who had not
had these experiences (Cunningham, et al., 2012). Therefore, factors closely related to
ethnicity, such as perceived discrimination, may contribute to changes in physiological
disruption.
Neighborhood stress was associated with elevated diurnal mean cortisol, but
not with circadian or immune disruption (Figure 4). Neighborhood stress was
significantly associated with diurnal cortisol mean, a measure of endocrine disruption.
Previous research has shown that individuals living in neighborhoods with increased
levels of perceived stressors had an increase of cortisol throughout the day and evening,
starting three hours after waking, and lower overall cortisol mean (Karb et al., 2012).
However, these stressors were not socioeconomic in nature, as Karb and colleagues
(2012) explored perceived neighborhood violence, safety, physical hazards, and quality
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of neighborhood service and observed homicides, robberies and burglaries, physical
disorder and deterioration, vacant lots and houses, and stress conditions (Karb et al.,
2012). Neighborhood violence has been shown to be associated with low waking cortisol,
and a “weaker, less consistent” association with neighborhood poverty and cortisol slope
(Do et al., 2011, p. 630). Furthermore, research has shown associations between total
serum cortisol and a neighborhood stress index comprised of unemployment rates,
poverty, female head of households with dependent children, and vacant housing (DulinKeita et al., 2012).
The differences in findings in this study and the literature may be due to differing
methods of measurement of cortisol, as well as differences in what neighborhood
stressors were explored. As demonstrated among adolescents living in neighborhoods
perceived as discriminatory (Huynh et al., 2016), it is possible that living in a
neighborhood that can be considered dangerous or socioeconomically stressful has an
impact on physiological disruption by increasing secretion of cortisol. Within this sample
of women, those living in areas with high neighborhood stress may have been
experiencing these stressors for an extended period, which could manifest in stress that is
chronic in nature. It may be that chronic neighborhood stress functions similarly to other
chronic stressors, contributing to increasing overall cortisol production in response to the
stress, which, in turn, may have harmful effects on health.
Neighborhood stress was not significantly related to circadian disruption. No data
on neighborhood stress and rest/activity rhythms is available. For comparison purposes,
neighborhood stress has been shown to be related to sleep (Hale et al., 2010; Hill et al.,
2009; Steptoe et al., 2008). It is important to note that while there is a probable
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correlation between rest/activity rhythms and sleep, these are different parameters.
Rest/activity rhythms are measured over multiple days and are based on circadian
patterns of activity. Research has focused exclusively on relations with sleep and
neighborhood disorder and crime. The differences in measures of neighborhood stress, as
well as assessing sleep, rather than rest/activity rhythms, may explain the discrepancies in
findings seen in previous research and this study. One study exploring the relationship
between sleep and neighborhood stress found that this association was no longer
significant after adjusting for self-reported health (Steptoe et al., 2008).
Neighborhood stress was not significantly related to immune disruption. While no
significant findings were seen in this study, this is an exciting area for further research as
the literature on stress and immune function is vast, and one article exploring the
relationship between neighborhood stress and health suggested that immune function may
mediate this relationship (Steptoe & Feldman, 2001). In a study of NH Whites and
African Americans, middle to older age adults living in more deprived neighborhoods
had greater odds of inflammation than those who live in less deprived areas (Dulin Keita,
Judd, Howard, Carson, Ard, & Fernandez, 2014). Additionally, greater neighborhood
deprivation was related to greater levels of IL-6, CRP, and fibrinogen (i.e., a protein for
clotting; Nazmi, Roux, Ranjit, Seeman, & Jenny, 2010). Exploring the possible role of
neighborhood stress on immune function within a cancer population could yield
significant findings that may help us understand how neighborhood stress may affect
physiology relevant to cancer. Additionally, in this study we explored relationships in the
context of an active tumor (i.e., presurgically). It is possible that tumor influences on
immune disruption could introduce variance that could mask stress-immune effects.
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To understand relationships between neighborhood stress and physiological
disruption, the length of time the individual lived in a particular neighborhood should be
considered. This is relevant in determining whether neighborhood stress could be
considered an acute or chronic source of stress for the individual. If neighborhood stress
for the individual is acute in nature, we may not see effects on physiological disruption. If
the individual recently moved from a neighborhood of high stress to an area of low stress,
we may see significant findings given the variation in amount of time spent in the current
neighborhood and the potential for sustained effects from living in the prior
neighborhood. However, it is possible in this scenario to not see associations between
neighborhood stress and physiological disruption due to possible improved access or
resources if one moves from a neighborhood with high stress to a neighborhood with low
stress. Access to resources (e.g., transportation, medical facilities) may explain
relationships observed when exploring the effects of neighborhood stress.
A theoretical framework has been developed to understand cancer disparities in
relation to neighborhood chronic toxic stress exposure (DeGuzman & Schminkey, 2016).
This model proposes that the social and built environment; which is a product of
historical events (e.g., racial segregation) and neighborhood associated chronic toxic
stressors (e.g., violence), influence health behaviors, mental health, and genomics (i.e.,
genomic epigenetic modifications and DNA damage); which in turn, affect cancer
outcomes (DeGuzman & Schminkey, 2016). Considering this model of the complex
effects of neighborhood stress on cancer increases the interest regarding the influence of
neighborhood stress of physiological disruption, as well as the potential associated effects
on outcomes (e.g., quality and quantity of life) in cancer patients.
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Cancer-related stress was associated with greater diurnal cortisol
rhythmicity. This association may be explained by adaptive avoidance of cancerrelated thought. Interestingly, within our sample of presurgical breast cancer patients,
cancer-related stress was related to steeper, more rhythmic cortisol slopes. Post hoc
analyses revealed a significant relationship between avoidance, but not intrusions, and
these “healthier” diurnal cortisol slopes. The avoidance subscale includes staying away
from reminders; avoidance of emotions; thought suppression; not trying to “deal with”
the negative emotions and difficulties; trying to remove an event from memory; and not
talking about the event. It is possible that within this sample of women, these strategies of
avoidance provided a buffering effect for the acute stressor that is a breast cancer
diagnosis. Research from our lab exploring daily intrusions and daily avoidant coping
relationships with diurnal cortisol slope did not emerge as significant in this same sample
of women (Dedert et al., 2012). Differing strategies in data collection included daily
intrusions and daily avoidant coping measured each day over three days, during the
cortisol collection in the study by Dedert and colleagues (2012). Additionally, avoidant
coping was measured using subscales of the Brief COPE measure (Dedert et al., 2012),
whereas this study utilized the IES. The difference in data collection may account for the
differences in findings.
The presurgical phase includes medical evaluations and preparation for surgery
and is often associated with significant mood disturbance and elevated distress in
relation to sleep difficulties, fatigue, and concentration difficulties in women with breast
cancer (Cimprich, 1999). Further, the pre-treatment period was the most stressful for
women with breast cancer (Culver, Arena, Antoni, & Carver, 2002; Northouse, 1998)

	
  

105

	
  
with the distress decreasing over time following initial diagnosis (Compas & Luecken,
2002; Culver et al., 2002; Burgess et al., 2005). Among men with prostate cancer who
had completed treatment, avoidant coping was found to be related to flatter diurnal
cortisol slopes at baseline and four-month follow-up (Hoyt et al., 2014). Given the
differences between our findings and those who have completed treatments, it may be
that avoidance provides a safeguard to changes in circadian regulation during the acutely
stressful presurgical period, but may have detrimental effects on physiology during the
post-treatment period or in response to chronic stress.
Cancer-related stress was not significantly related to circadian disruption. Limited
research has explored the relationship between cancer-specific distress, a measure of
intrusions and avoidance, and circadian rhythms. Research conducted on this same
sample of women by our lab showed associations between daily intrusions and daily
avoidant coping with consistency of rest/activity rhythms, daytime sedentariness, and
nighttime restlessness (Dedert et al., 2012). However, the collection strategy for cancerrelated stress (i.e., intrusions and avoidance) differed, in that this study explored cancerrelated stress at one-time point, baseline, whereas the study by Dedert and colleagues
(2012) explored these variables daily over the same three days that actigraphy was
collected. The average (SD) days between our collection at baseline and the actigraphy
collection were 0.167 days (3.975), with a median of one day. The discrepancy in
findings may be explained by day-to-day variability. Therefore, it may be that nuanced
variations in daily levels of intrusions and avoidant coping are better predictors of
circadian disruption than obtaining data on a patient’s average levels over the past week.
It may be that in the days following a cancer diagnosis, cancer-related stress may increase
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as the individual has had more opportunity to reflect on their diagnosis and the
implications that the diagnosis and treatment will have on their quality and quantity of
life. Additionally, it is possible that individually, either intrusions or avoidance may be
better associated with circadian disruption than the combination of the two.
Cancer-related stress was not associated with other measures of endocrine
disruption (i.e., CAR slope and diurnal cortisol mean). Research completed by our lab,
using the same sample of women, did not observe associations between daily intrusions
or daily avoidant coping with CAR slope or diurnal mean cortisol (Dedert et al., 2012).
Other previous research has shown that intrusions and avoidance might be related to
cortisol alterations. One meta-analysis indicated that following a traumatic event, there
might be increases in cortisol production, but generally, cortisol levels are lower in
individuals with PTSD (Yehuda, 2002). This contrasts with our sample as PTSD
develops after at least one month of symptoms following a traumatic event; whereas,
data was collected in our sample an average (SD) of 19.21 (20.82) days after diagnosis,
with a median of 14 days. Within a sample of healthy women with no personal or family
histories of breast cancer, breast cancer specific intrusions were related to increased
cortisol responses to acute stressors at work (Dettenborn et al., 2006).
Cancer-related stress was not significantly related to immune disruption. Prior
research has shown increased cancer-related stress to be related to inhibition of cellular
immune response (Andersen et al., 1998), decline in natural killer cell activity and
stimulated IFN-γ (Von Ah et al., 2007), and elevations of plasma IL-1Rα (Mundy-Bosse
et al., 2011) among post-surgical breast cancer patients. In metastatic breast cancer
patients, depression was related to suppressed immunity (Sephton et al., 2009).
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Additionally, in ovarian cancer patients, increased vegetative depression was associated
with elevated plasma IL-6 (Lutgendorf et al., 2008) and increased helplessness was
related to increased serum VEGF (Lutgendorf et al., 2002). It is possible that the lack of
findings in this study may be due to differences in measurements of distress (e.g.,
cancer-related stress vs. depression) and immune function (e.g., serum vs. stimulated
cytokines), as well as timing of data collection (e.g., presurgical vs. post-surgical).
In this study, the timing of the measurement of variables, including cancer-related
stress and physiological disruption, was prior to any surgical procedure. Receiving a
cancer diagnosis can be regarded as an acutely stressful period, and it may be that this
period of stress has not been experienced for a long enough amount of time to be related
to or cause changes in physiological disruption, which could explain the lack of findings.
It is also possible that in the short term, avoidance, one aspect of cancer-related stress,
may provide effects that protect against changes to physiology. Avoidance has been
conceptualized to include denial (Taylor & Stanton, 2007), which is “trying to push the
reality of the situation away” (Carver, 1997, p.98). In addition to denial, avoidance also
includes repression, distraction, and disengagement (Carver, Scheier, & Weintraub,
1989). In a study of women with breast cancer, within one week following mastectomy,
denial was associated with lower levels of stress, which indicates that denial may be a
short term adaptive coping response to a diagnosis of cancer (Watson, Greer, Blake, &
Shrapnell, 1984). Denial was also seen in a sample of lung cancer patients, which the
authors suggest is normal and highlights a need to protect one’s self from the stress
associated with a cancer diagnosis, and that over time use of denial and distraction
decrease (Vos, Putter, van Houwelingen, & de Haes, 2008). It is possible that maintaining
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as much normalcy as possible during the early phases of the cancer trajectory may prove
beneficial in managing the short-term stress of a diagnosis. However, longitudinal
research within a cancer population may elucidate the risks and benefits of various types
of coping throughout cancer diagnosis, treatment, and survivorship. Indeed, in a sample
of women with early stage breast cancer, denial and a fighting spirit were significantly
more likely to be predictive of five-year survival than stoic acceptance of
hopelessness/helplessness (Greer, Morris, & Pettingale, 1979).
No predictors of progression-free survival emerged.
Measures of psychosocial stress (i.e., ethnicity, neighborhood stress, and cancerrelated stress) were not significantly related to medical outcomes of cancer (progressionfree survival) in this study. These findings are inconsistent with previous literature that
shows significant ethnic disparity in cancer survival; however, the previous research has
largely been epidemiological in nature.
Disparities in survival rates among NH White and African American breast
cancer patients may be attributed to racial differences in patterns of care (Diehr et al.,
1989), treatment options and choices (Bradley, Given, & Roberts, 2002; Hershman et al.,
2005), barriers to access to care (DeSantis, Siegel, Bandi, & Jemal, 2011),
noncompliance with therapy, and incomplete treatment adherence, which may be related
to socioeconomic status (Baquet, Mishra, Commiskey, Ellison, & DeShields, 2008).
However, it has been suggested that the ethnic disparity in mortality may be due to
factors other than those related to access to care (Chlebowski et al., 2005). For example,
ethnic differences in genetics, which may also be attributed to neighborhood stress, could
explain differences in cancer outcomes (DeGuzman & Schminkey, 2016). Therefore,
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cross-sectional, experimental, and longitudinal research would be beneficial to help
elucidate these disparities.
There are possible explanations for the lack of significant findings in this study. It
is possible that the sample size for those who have had recurrent disease or have passed
was too small to detect significant effects. With survival analyses, it is suggested that at
least 50% of participants should have experienced a recorded event (i.e., recurrence or
death in this study). This study only had 30% of participants that had recurrent disease or
passed; therefore, this may have been too small a proportion to detect significant effects.
Another, related, possibility is that of missing data. Considering the low number of
participants for whom survival data were available (n = 16), analyses may have been
underpowered.
Measures of physiological disruption (i.e., circadian, endocrine, and immune)
were not significantly related to progression-free survival. These findings are inconsistent
with previous literature that have shown rest/activity rhythms (Innominato et al., 2009;
Lévi et al., 2014; Mormont et al., 2000), diurnal cortisol slope (Cohen et al., 2012;
Schrepf et al., 2015; Sephton et al., 2013; Sephton et al., 2000), VEGF (Jin-no et al.,
1998; Karayiannakis et al., 2002), and IL-1β (Barber et al., 2000) to be associated with
shorter survival in various cancer populations. As described above, it is possible that the
small sample size provided too little statistical power to reveal significant findings. In
addition, it is possible that no significant findings were observed because this sample of
women was presurgical. It is plausible that presurgical cancer patients have not had
significant changes to physiological disruption markers that affect survival (Cash et al.,
2015). If this is the case, these results could be promising in that interventions targeted
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during the presurgical period, or prior to neoadjuvant treatment may delay physiological
disruption, or weaken the effects of physiological disruption on survival.
Extensive research has shown that various psychosocial interventions decrease
stress related to the experiences of cancer diagnosis and treatment, which may improve
physiology throughout and following treatment (Antoni, 2013). However, prehabilitation
research is a nascent area within the cancer rehabilitation continuum, which focuses on
the time between diagnosis and the beginning of treatment (Silver, 2015). Preoperative
interventions can focus on physical functioning, nutrition, psychological health, and
stress management, which may influence physiological and psychological outcomes in
patients with cancer (Silver, 2015). Indeed, a review of the cancer prehabilitation
literature revealed that preoperative psychological interventions had significant effects on
immune function, psychological outcomes, somatic symptoms, and quality of life
(Tsimopoulou et al., 2015).
Associations have been observed between psychosocial stress and physiological
disruption with another cancer outcome, quality of life (QOL). In a study exploring the
relationships between distress and QOL with this same sample of women, an association
between cancer-related stress and QOL, as well as ethnic differences were observed
(Rebholz et al., 2016). For example, NH White women reported poorer emotional QOL
in relation to cancer-related distress, which may indicate that African American women
utilize more effective means of coping or rely on or experience more positive social
support (Rebholz et al., 2016). Research has shown that African Americans are more
likely to use spirituality in coping with cancer-related stressors (Culver, Arena, Antoni, &
Carver, 2002). Additionally, research has shown relationships between circadian
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disruption (Innominato et al., 2009) and endocrine disruption (Carlson, Speca, Patel, &
Goodey, 2004; Miller, Ancoli-Israel, Bower, Capuron, & Irwin, 2008) and QOL. IL-6 has
also been shown to be associated with fatigue, which strongly affects QOL in cancer
patients (Cleeland et al., 2003; Seruga, Zhang, Bernstein, & Tannock, 2008).
Low-income patients had poor circadian coordination.
In analyses exploring associations between psychosocial stress and circadian
disruption, patients reporting lower income had greater circadian disruption, indicated by
less rhythmic rest/activity patterns and greater daytime sedentary behavior. Within this
same sample of women, lower income was associated with greater rest/activity disruption
in tests of associations with daily intrusions and daily avoidant coping (Dedert et al.,
2012). Income likely serves as a significant source of stress, which may negatively
impact rest/activity rhythms. Therefore, income disadvantage appears to play a role in
circadian disruption and should be further explored to understand the mechanisms driving
this association.
Additionally, income emerged as a significant predictor in the analysis assessing
the relationship between neighborhood stress and endocrine disruption, such that patients
reporting lower income levels had flatter diurnal cortisol slopes, which are indicative of a
less healthy profile. In a large study of older adults, financial insecurity explained a
portion of the variance in the relationship between social position and cortisol slope
(Kumari et al., 2010). Lower socioeconomic status was related to lower waking cortisol
levels and flatter cortisol slopes in the early portion of the day (Hajat et al., 2010). In
contrast, higher income has been shown to be related to steeper cortisol decline over the
day (Wang et al., 2014). The findings of this study support previous literature that

	
  

112

	
  
income, one measure of an individual’s socioeconomic status, may serve as a source of
stress that influences endocrine physiology. Disadvantage related to low income is a
significant stressor to many individuals and is potentially more salient to those affected
by cancer as they face treatment decisions that are likely to influence various areas of life
related to income, such as the ability to work or care for family and the home. Continued
research is needed to better understand the role income plays in chronic endocrine
changes, as socioeconomic disadvantage may influence cancer progression.
Younger patients had greater immune disruption.
In the analyses assessing the associations of psychosocial stress and immune
disruption, younger patients had greater secretion of inflammatory/TH1-type cytokines
(i.e., IL-6, IL-12, IFN-γ). Research has shown that younger women with breast cancer are
often diagnosed at a later stage and have adverse pathology as evidenced by higher grade
tumors, negative hormone receptor status, and overexpression of HER2 (Assi et al.,
2013). Research has shown IL-6 levels increase as one ages in samples of older adults
(Kiecolt-Glaser, Preacher, MacCallum, Atkinson, Malarkey, & Glaser, 2003), healthy
subjects (Wei, Xu, Davies, & Hemmings, 1992), and women (Haden, Glowacki, Hurwitz,
Rosen, & LeBoff, 2000). While these findings are in the opposite direction as those we
observed, our results are not surprising given the more difficult prognosis of younger
breast cancer patients and the likely associated stress. Further research should explore
relationships between age and these cytokines in breast cancer patients to understand how
age may influence inflammation/TH1-type immunity. Better understanding this potential
relationship may lead to avenues for treatment that could improve outcomes for younger
breast cancer patients.
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Strengths and Limitations
This study represents the first examination of multiple types of psychosocial
stress and physiological disruption in presurgical breast cancer patients. By examining
ethnicity, the impact of the environment (i.e., neighborhood), one’s perception of stress
related to a cancer diagnosis, and changes in physiology through the use of subjective
self-report measures, census data, and objective measures allowing for a more
comprehensive evaluation of stress. Therefore, by collecting data on multiple sources of
stress measured with different methods, it is possible to explore the importance of both
psychosocial stress and physiological disruption during the cancer process.
Utilizing census data to study the effects of neighborhood stress is an approach
that allows for a more accurate reflection of the status of the neighborhood, reflected as a
census tract, compared to obtaining self-report of one’s perceptions of their neighborhood
stress. Both methods of measurement hold merit to use in research; however, by utilizing
census data, it is possible to obtain an objective understanding of neighborhood stress. By
conducting a principal components analysis (PCA), it was possible to explore four
variables that loaded onto one factor, neighborhood stress. This helped to limit the
number of analyses run when exploring the effects of neighborhood stress on
physiological disruption and medical outcomes of cancer.
Measuring circadian disruption with two indicators (i.e., rest/activity rhythms and
diurnal cortisol rhythms) allows for these two types of circadian rhythms to be measured
via separate and objective methodology (i.e., activity levels and salivary cortisol levels,
respectively). Actigraphy data may be more likely to be influenced by exogenous factors,
which, for example, may include cues from the social environment (e.g., light exposure,
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meal timing). Diurnal cortisol measurement depicts endogenous rhythms regulated by the
SCN.
For multiple reasons, a novel aspect of this study is the timing of recruitment and
data collection, which occurred relatively soon after the cancer diagnosis and prior to
surgical treatment. There is a dearth of research during this time point, with the majority
of studies focusing on patients during adjuvant treatment or those with survivor status
(i.e., greater than or equal to five years disease-free). By assessing mental and emotional
state and physiology prior to surgery and other treatments, it is possible to gain an
understanding of these variables with an active tumor present in the body. Our data were
not clouded by variability resulting from physically and emotionally demanding cancer
treatments. Additionally, by conducting assessments at this time point it is possible to
assess psychosocial and biological constructs before the long-term cancer treatment
process alters them. By assessing physiology presurgically and prior to other types of
treatment (e.g., neoadjuvant chemotherapy and radiation therapy), systems have not yet
been dysregulated by these medical interventions.
It is noteworthy that this sample was ethnically diverse. The ethnic breakdown of
the sample was approximately 58% NH White and about 37% African American. There
were an additional three participants, two reporting their ethnicity as Native American
and one reporting her ethnicity as Asian American. These three individuals were
excluded from the analyses utilizing ethnicity as a predictor, due to potential cultural
differences in psychosocial stress and physiological disruption. Rather than grouping the
individuals into a general minority category, it is preferable to consider the different
cultural factors of each specific ethnic group. Additionally, given the small sample size of
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Native Americans and Asian Americans, it was necessary to exclude them from the
analyses.
The overall relatively small sample size of the study is itself another limitation. A
larger study would provide greater power and allow for the detection of small magnitude
effects (i.e., phenomena with smaller effect sizes). Additionally, there were missing data,
which coupled with the small sample size created problems with the survival analyses.
No survival analyses emerged as significant. This is likely, in part, due to the low number
of participants with a recorded event (i.e., 30% of participants with recurrence or death)
once predictor-missing data were accounted for. The number of events was already low
for survival analyses and once the removal of those with missing data, the number was
even lower.
This study was exploratory in nature. This was an approach that was taken to
provide direction for the generation of hypotheses in future research studies, rather than
to confirm hypotheses. Therefore, the results presented here should be considered with
caution as they are not generalizable outside this sample. Given the large number of
analyses that were run, results must be interpreted with great caution. Our many nonsignificant findings could be attributable to the small sample size, or may be due to
differences in data collection and statistical tests compared to previous studies. However,
given the exploratory nature of the study, the results should serve as a guide for the
development of future research and relationships that were not significant should be
explored further.
Future Directions
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The results of this study point to a number of directions for additional research to
explore. It is reasonable to think that some aspects of psychosocial stress may influence
physiological disruption early in the cancer trajectory, even before any surgical or
medical intervention. Further studying the impact of psychosocial stress on physiological
disruption within cancer populations may provide an even greater understanding of how
stress affects physiology when an individual experiences chronic disease.
It may be beneficial to consider the manner in which the psychosocial factors are
measured in research. This study used a dichotomous self-report of ethnicity; however, an
improved manner for measuring ethnicity would be to utilize a validated measure, such as
the Multigroup Ethnic Identity Measure (MEIM; Phinney, 1992; Phinney & Ong, 2007).
The MEIM would be more beneficial than a dichotomous or categorical self-report of
ethnicity, as it would allow for a better understanding of one’s ethnic identity, sense of
belonging with their ethnic origin, and the possible impact that this has on physiological
disruption.
With regard to neighborhood stress, it would be useful for future research to
include an index, as this study did, to assess various factors that may impact
physiological disruption. By utilizing an index of neighborhood stress, researchers would
be able to explore various areas, such as neighborhood poverty levels, median
neighborhood income, and other factors, that may contribute to the difficulty of living in
a particular neighborhood. This could allow for a better understanding of what individual
factors may contribute to changes in physiological disruption. Additionally, knowledge
would be gained as to the impact of the cumulative nature of environmental stressors
within the neighborhood context.
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Mediator and moderator variables were not explored in this study for multiple
reasons, including the small sample size and that the study sought to utilize exploratory
analyses to gain a better understanding of direct relationships between psychosocial stress
and physiological disruption. However, the role of mediators and moderators are essential
in better understanding the relationships between psychosocial stress and physiological
disruption. Potential mediators and moderators that would be advantageous to study
include access to and utilization of healthcare, social support, coping resources, which
may include active coping strategies, religiosity or spirituality, and meaning making or
benefit finding. While this list is not exhaustive, it highlights potential variables of
significance.
While this study employed a cross-sectional design, longitudinal research could
illuminate how psychosocial stress and physiological disruption change over time. It is
likely that there is a time during the cancer trajectory that psychosocial stress and
physiological disruption are stronger predictors of one another, as well as stronger
predictors of survival. A longitudinal design can allow for hierarchical linear modeling,
which can illuminate the period during which psychosocial factors most strongly predict
cancer outcomes. From gaining this type of knowledge, substantial implications for
medical and psychological intervention would result. By knowing what psychosocial
stress or physiological disruption factor is a stronger predictor at a particular time during
one’s cancer journey, more assessments could be completed during that period, which
might lead to either psychological or medical interventions to improve the quality or
extend the quantity of life for individuals with cancer.
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Future research that investigates psychosocial stress would benefit from including
ethnicity and neighborhood stress, in addition to an individual’s perceived stress related
to their diagnosis. With these additions, research will more adequately explore various
stressors that may play a role in physiological disruption. By continuing to explore these
associations, research can begin to understand more about the driving factors of
physiological disruption. This may help to identify the most predictive aspects of stress,
identify future medical and clinical treatments, and delay or prevent adverse changes to
physiology/health outcomes.
Research should continue to explore the mechanisms of stress effects on cancer
survival. Research in which assessments are completed prior to surgery or other medical
intervention is crucial. Research of this nature may shed light on the effects of an active
tumor on physiological disruption and the possible implications throughout the cancer
trajectory, as well as the individual’s lifespan. If associations are seen between early
onset psychosocial stress, physiological disruption, and survival; we may discover new
markers to target early in the cancer process.
The current study explored novel relationships between psychosocial stress and
physiological disruption within a sample of women that were awaiting surgery for breast
cancer. The association between neighborhood stress and endocrine physiology
emphasizes the importance of improved resources and access within disadvantaged
neighborhoods, which would likely reduce stress and improve resident’s health. An
unexpected relationship between avoidance and healthier diurnal cortisol slopes
indicates that avoidance may serve to help maintain normalcy during the acutely
stressful, chaotic, presurgical period. These intriguing findings highlight the importance
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of psychosocial intervention while awaiting treatment for cancer. Prehabilitation
interventions, when psychosocial stress is probably most salient to a woman with cancer,
are worthy of investigation. Research of this nature could aid in identifying methods for
improvement of quality, and possibly quantity, of life for women with breast cancer.
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APPENDIX A
Abbreviations: DCIS, ductal carcinoma in situ; TNM, tumor-node-metastasis; ER,
estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor
receptor 2; QOL, quality of life; SES, socioeconomic status; NH, non-Hispanic; ASD,
acute stress disorder; PTSD, post-traumatic stress disorder; DSM, Diagnostic and
Statistical Manual of Mental Disorders; SCN, suprachiasmatic nucleus; HPA,
hypothalamic-pituitary-adrenal; CAR, cortisol awakening response; VEGF, vascular
endothelial growth factor; MMP, matrix metalloproteinase; TGF, transforming growth
factor; IL-6R, interleukin-6 receptor; MCP, monocyte chemoattractant protein; IL,
interleukin; TNF, tumor necrosis factor; IFN, interferon; REM, rapid eye movement; GCSF, granulocyte-colony stimulating factor; CRP, C-reactive protein; SEER,
Surveillance, Epidemiology, and End Results Program; AUC, area under the curve; KCR,
Kentucky Cancer Registry; IES, Impact of Events Scale; MEMS, medication event
monitoring system; EIA, enzyme immunoassay; CV, coefficient of variation; EFA,
exploratory factor analysis; POM-TMD, Profile of Mood States- Total Mood
Disturbance; PCA, principal component analysis; KMO, Kaiser-Meyer-Olkin; MEIM,
Multigroup Ethnic Identity Measure
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APPENDIX B
Ethnicity (as measured in this study)
What is your racial-ethnic background?

	
  

O
O
O
O
O
O
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Asian
Black
Hispanic
Native American
White/Caucasian
Other

	
  

13.
14.
15.
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Often

5.
6.
7.
8.
9.
10.
11.
12.

Sometimes

3.
4.

I thought about it when I didn't mean to.
I avoided letting myself get upset when I thought about it or was
reminded of it.
I tried to remove it from memory.
I had trouble falling asleep or staying asleep, because of pictures of
thoughts about it that came into my mind.
I had waves of strong feelings about it.
I had dreams about it.
I stayed away from reminders of it.
I felt as if it hadn't happened or it wasn't real.
I tried not to talk about it.
Pictures about it popped into my mind.
Other things kept making me think about it.
I was aware that I still had a lot of feelings about it, but I didn't
deal with them.
I tried not to think about it.
Any reminder brought back feelings about it.
My feelings about it were kind of numb.

Rarely

1.
2.

Not at all

Measure of Cancer-Related Stress
Impact of Events Scale (IES; Horowitz et al., 1979)
Below is a list of comments made by people after stressful life events. Please fill in each
item, indicating how frequently the comments were true for you DURING THE
CURRENT DAY regarding your diagnosis and treatment of BREAST CANCER. If they
did not occur, please mark the "Not at All" column.

0
O

1
O

2
O

3
O

O

O

O

O

O

O

O

O

O

O

O

O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O

O

O

O

O
O
O

O
O
O

O
O
O

O
O
O

	
  

APPENDIX C
All results are presented here in full as a reference.
Spearman’s rho correlation matrix for hypothesis 1.
Mean (SD)
1
1. Ethnicity
--+
2. Neighborhood
0 (1)
-socioeconomic
stress
3. Cancer-related
28.38 (15.37)
-stress
* p < .001
+
variable is standardized

2
.615*
--

3
-.066
.172

--

--

Summary of results for hypothesis 2A.1: Hierarchical regression analyses entering
ethnicity as a predictor of circadian rhythm variables.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
Rest/activity rhythm
43
Step 1
.223
.223
.019*
Age
.003
.002
.209
Stage
.008
.011
.104
Income
.041
.013 .436*
Step 2
.257
.034
.195
Ethnicity
-.058
.052
-.170
Nighttime restfulness
43
Step 1
.093
.093
.277
Age
-.001
.042
-.005
Stage
.102
.269
.059
Income
.618
.314
.301
Step 2
.094
.000
.890
Ethnicity
-.180
1.298
-.024
Daytime sedentariness
43
Step 1
.185
.185
.045*
Age
-.087
.064
-.200
Stage
.244
.409
.088
Income
-1.221
.478 -.370*
Step 2
.189
.004
.655
Ethnicity
-.890
1.974
-.074
* p < .05
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Summary of results for hypothesis 2A.1: Hierarchical regression analyses entering
ethnicity as a predictor of endocrine disruption variables.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
CAR slope
36
Step 1
.041
.041
.714
Age
-.006
.007
-.166
Stage
.013
.044
.051
Income
.019
.053
.061
Step 2
.119
.078
.107
Ethnicity
.335
.202
.314
Diurnal cortisol slope
45
Step 1
.056
.056
.495
Age
-.001
.001
-.072
Stage
-.006
.007
-.133
Income
-.011
.008
-.201
Step 2
.056
.000
.908
Ethnicity
.004
.033
.020
Diurnal cortisol mean
45
Step 1
.070
.070
.391
Age
.009
.006
.245
Stage
.035
.038
.143
Income
-.002
.045
-.005
Step 2
.081
.011
.491
Ethnicity
.121
.174
.115
* p < .05
Summary of results for hypothesis 2A.1: Hierarchical regression analyses entering
ethnicity as a predictor of immune factor variables.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
Factor 1
36
Step 1
.054
.054
.616
Age
-.005
.010
-.078
Stage
-.088
.071
-.214
Income
-.056
.078
-.057
Step 2
.055
.001
.852
Ethnicity
-.066
.351
-.039
Factor 2
36
Step 1
.07
.076
.465
Age
.018
.013
.219
Stage
-.071
.091
-.132
Income
.071
.101
.120
Step 2
.161
.085
.085
Ethnicity
-.767
.432
-.344
Factor 3
36
Step 1
.342
.342
.004*
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Age
Stage
Income
Step 2
Ethnicity
* p < .05

-.045
-.105
-.040

.011
.077
.086

-.560*
-.194
-.067

.568

.372

.252

.388

.046

.137

Summary of results for hypothesis 2A.2: Hierarchical regression analyses entering
neighborhood socioeconomic stress as a predictor of circadian rhythm variables.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
Rest/activity rhythm
40
Step 1
.281
.281
.007*
Age
.003
.002
.214
Stage
.013
.011
.171
Income
.045
.013 .497*
Step 2
.282
.002
.763
Neighborhood
-.008
.027
-.048
socioeconomic stress
Nighttime restfulness
40
Step 1
.097
.097
.295
Age
-.006
.045
-.023
Stage
.292
.268
.176
Income
.532
.324
.262
Step 2
.099
.003
.747
Neighborhood
-.218
.671
-.058
socioeconomic stress
Daytime sedentariness
40
Step 1
.148
.148
.119
Age
-.075
.065
-.180
Stage
-.202
.389
-.081
Income
-1.092
.471 -.359*
Step 2
.163
.014
.444
Neighborhood
.750
.968
.133
socioeconomic stress
* p < .05
Summary of results for hypothesis 2A.2: Hierarchical regression analyses entering
neighborhood socioeconomic stress as a predictor of endocrine disruption variables.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
CAR slope
34
Step 1
.046
.046
.696
Age
-.007
.007
-.183
Stage
.005
.043
.023
Income
.026
.053
.089
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Step 2
Neighborhood
socioeconomic stress
Diurnal cortisol slope
Step 1
Age
Stage
Income
Step 2
Neighborhood
socioeconomic stress
Diurnal cortisol mean
Step 1
Age
Stage
Income
Step 2
Neighborhood
socioeconomic stress
* p < .05

-.141

.136

.080

.034

.308

.138

.138

.135

.139

.001

.829

.090

.090

.314

.336

.246

.001*

-.211

41
-.001
-.001
-.018

.001
.006
.007

-.111
-.021
-.366*

-.003

-.015

-.037

.011
.027
-.022

.006
.038
.046

.277
.113
-.076

.290

.079

.537

41

Summary of results for hypothesis 2A.2: Hierarchical regression analyses entering
neighborhood socioeconomic stress as a predictor of immune factor variables.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
Factor 1
34
Step 1
.076
.076
.490
Age
-.008
.011
-.126
Stage
-.036
.069
-.091
Income
-.114
.080
-.253
Step 2
.180
.103
.066
Neighborhood
-.309
.162
-.356
socioeconomic stress
Factor 2
34
Step 1
.032
.032
.803
Age
.013
.015
.163
Stage
-.017
.088
-.034
Income
.048
.102
.086
Step 2
.049
.017
.477
Neighborhood
-.156
.217
-.145
socioeconomic stress
Factor 3
34
Step 1
.438
.438
.001*
Age
-.046
.011 -.602*
Stage
-.150
.064 -.324*
Income
-.070
.074
-.950
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Step 2
Neighborhood
socioeconomic stress
* p < .05

.473
.213

.154

.035

.177

.207

Summary of results for hypothesis 2A.3: Hierarchical regression analyses entering
cancer-related stress as a predictor of circadian rhythm variables.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
Rest/activity rhythm
45
Step 1
.236
.236
.011*
Age
.002
.002
.191
Stage
.010
.011
.127
Income
.041
.012 .461*
Step 2
.176
.015
.374
Cancer-related stress
-.001
.001
-.123
Nighttime restfulness
45
Step 1
.092
.092
.262
Age
.000
.039
.000
Stage
.246
.250
.149
Income
.523
.291
.269
Step 2
.092
.000
.972
Cancer-related stress
.001
.034
.005
Daytime sedentariness
45
Step 1
.156
.156
.071
Age
-.074
.058
-.188
Stage
-.140
.366
-.056
Income
-1.087
.426 -.368*
Step 2
.160
.004
.664
Cancer-related stress
.022
.050
.064
* p < .05
Summary of results for hypothesis 2A.3: Hierarchical regression analyses entering
cancer-related stress as a predictor of endocrine disruption variables.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
CAR slope
39
Step 1
.042
.042
.674
Age
-.006
.006
-.181
Stage
.003
.040
.014
Income
.019
.049
.067
Step 2
.058
.016
.455
Cancer-related stress
-.004
.005
-.129
Diurnal cortisol slope
47
Step 1
.071
.071
.358
Age
-.001
.001
-.099
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Stage
Income
Step 2
Cancer-related stress
Diurnal cortisol mean
Step 1
Age
Stage
Income
Step 2
Cancer-related stress
* p < .05

-.002
-.013

.006
.008

-.053
-.258

-.002

.001

-.292

.008
.041
.003

.006
.036
.043

.227
.169
.011

.007

.005

.227

.156

.084

.047*

.067

.067

.391

.118

.051

.127

47

Summary of results for hypothesis 2A.3: Hierarchical regression analyses entering
cancer-related stress as a predictor of immune factor variables.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
Factor 1
39
Step 1
.050
.050
.608
Age
-.002
.011
-.037
Stage
-.060
.069
-.144
Income
-.085
.079
-.180
Step 2
.051
.001
.853
Cancer-related stress
-.002
.009
-.031
Factor 2
39
Step 1
.064
.064
.502
Age
.018
.013
.227
Stage
-.046
.082
-.092
Income
.040
.094
.070
Step 2
.074
.010
.551
Cancer-related stress
.007
.011
.100
Factor 3
39
Step 1
.288
.288
.007*
Age
-.040
.011 -.505*
Stage
-.116
.073
-.229
Income
-.069
.083
-.120
Step 2
.315
.028
.248
Cancer-related stress
.011
.009
.168
* p < .05
Summary of results for hypothesis 2B.1: Cox proportional hazards model entering
ethnicity as a predictor of progression-free survival.
B
SE B
Wald
Hazards Ratio 95% Confidence Interval
Time Since DD
Ethnicity
.157 .579
.073
1.170
.376-3.637
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Time Since SE+
Ethnicity
-.078 .542
.021
.925
* p < .05
+
Study entry (SE) calculated from date of first cortisol collection

.320-2.678

Summary of results for hypothesis 2B.2: Cox proportional hazards model entering
neighborhood socioeconomic stress as a predictor of progression-free survival.
B
SE B Wald Hazards Ratio 95% Confidence Interval
Time Since DD
Neighborhood
.302
.263
1.319
1.352
.808-2.263
socioeconomic
stress
Time Since SE+
Neighborhood
.271
.257
1.112
1.311
.793-2.168
socioeconomic
stress
* p < .05
+
Study entry (SE) calculated from date of first cortisol collection
Summary of results for hypothesis 2B.3: Cox proportional hazards model entering
cancer-related stress as a predictor of progression-free survival.
B
SE B
Wald
Hazards Ratio 95% Confidence Interval
Time Since DD
Cancer-related
-.001
.020
.003
.999
.961-1.038
stress
Time Since SE+
Cancer-related
-.014
.019
.569
.986
.950-1.023
stress
* p < .05
+
Study entry (SE) calculated from date of stress assessment
Summary of results for hypothesis 2C.1: Cox proportional hazards model entering
circadian disruption variables as predictors of progression-free survival.
B
SE B
Wald
Hazards Ratio 95% Confidence Interval
Time Since DD
Rest/activity
.712 1.539
.214
2.038
.100-41.633
rhythm
Nighttime
restfulness
Daytime
sedentariness
	
  

-.012

.082

.880

1.012

.862-1.188

.000

.050

.000

1.000

.907-1.103
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Time Since SE+
Rest/activity
rhythm
Nighttime
restfulness

.910

1.524

.356

2.484

.125-49.285

-.016

.082

.040

1.016

.865-1.194

Daytime
-.002
.050
.001
.998
sedentariness
* p < .05
+
Study entry (SE) calculated from date of first actigraphy assessment

.904-1.102

Summary of results for hypothesis 2C.2: Cox proportional hazards model entering
endocrine disruption variables as predictors of progression-free survival.
B
SE B
Wald
Hazards Ratio 95% Confidence Interval
Time Since DD
CAR slope
.470
.739
.404
1.599
.376-6.806
Diurnal cortisol
slope

.093

3.166

.001

1.098

.002-543.143

Diurnal cortisol
mean
Time Since SE+
CAR slope

.463

.531

.762

1.589

.562-4.496

.404

.731

.306

1.498

.357-6.281

Diurnal cortisol
slope

1.207

2.926

.170

3.343

.011-1035.063

Diurnal cortisol
.421
.498
.716
1.524
mean
* p < .05
+
Study entry (SE) calculated from date of first cortisol collection

.574-4.045

Summary of results for hypothesis 2C.3: Cox proportional hazards model entering
immune factors as predictors of progression-free survival.
B
SE B
Wald
Hazards Ratio 95% Confidence Interval
Time Since DD
Factor 1
-.168
.258
.422
.846
.510-1.402

	
  

Factor 2

-.108

.359

.091

.897

.444-1.812

Factor 3
Time Since SE+

-.123

.304

.163

.884

.487-1.606
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Factor 1

-.168

.251

.448

.846

.518-1.382

Factor 2

-.226

.338

.447

.798

.412-1.546

.807

.456-1.428

Factor 3
-.214
.291
.542
* p < .05
+
Study entry (SE) calculated from date of blood draw

Summary of results for post hoc analyses: Hierarchical regression analyses entered
cancer-related stress subscales as a predictor of diurnal cortisol slope.
Variable
N
B
SE B
R2
β
ΔR2 p of ΔR2
Diurnal Cortisol Slope
48
Step 1
.091
.091
.234
Age
-.001
.001
-.124
Stage
-.003
.006
-.077
Income
-.015
.008
-.283
Step 2
.107
.015
.395
Cancer-related stress:
-.001
.002
-.124
Intrusions
Step 2
.244
.153
.005*
Cancer-related stress:
-.004
.001
-.399
Avoidance
* p < .05
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breast cancer patients? Poster Presentation at the San Antonio Breast Cancer
Symposium, San Antonio, TX.
Gesler, W., Dhabhar, F., Chagpar, A., Dedert, E., Lush, E., Daup, M., Dayyat, E.,
McMasters, K., Sephton, S.E. (2010). Distress and Inflammation in Women
Newly Diagnosed with Breast Cancer. Poster Presentation at the James Graham
Brown Cancer Center Ninth Annual Retreat, Louisville, KY.
Manuscripts in Preparation
Rebholz, W.N.; Cash, E.; Bayley, R.C.; Zimmaro, L.A.; Phillips, K.; Siwik, C.; Sephton,
S.E. Diurnal Cortisol Rhythm and Norepinephrine Predict Gynecologic Cancer
Survival. To be submitted to Journal of the National Cancer Institute.
Jablonski, M. E.; Dreeben, S.; Hanneman, S.; Vines, L.; Rebholz, W.N.; Bayley, R.;
Eismann, E.; Sephton, S.E.; Litvan, I.; Houghton, D.; Constantino, A.; Salmon,
P. A Randomized-Controlled Pilot Study of Mindfulness-Based Stress Reduction
(MBSR) for Early-Stage Parkinson’s Disease Patient and Caregiver Dyads.
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Rebholz, W.N.; Weissbecker, I.; Cash, E.; Bayley, R.C.; Sephton, S.E. Distress and
Support: Links with Circadian Disruption and Quality of Life in Gynecologic
Cancer. To be submitted to Psychoneuroendocrinology.
Bayley, R., Rebholz, W.N., Cash, E., Weissbecker, I., Salmon, P., Sephton, S.
Associations between Trauma Across the Lifespan, Health Behaviors, and
Allostatic Load in Gynecologic Cancer Patients.
Sephton, S.E.; Cash, E.; Chagpar, A.B.; Spiegel, D.; Rebholz, W.N.; Bayley, R.C.;
Zimmaro, L.Z.; Dhabhar, F.S. Breast Cancer, Circadian Disruption, and
Stimulated Immunity. To be submitted to Brain, Behavior, Immunity.
Rebholz, W.N.; Sephton, S.E. The Effects of Coping and Social Support on Physiology
in Patients with Lung Cancer.
Zimmaro, L.A.; Cash, E.; Rebholz, W.N.; Bayley, R.C.; Sephton, S.E. Mindfulness,
Sleep, and Circadian Rhythms.
Clinical Experience
July 2015-July 2016
Predoctoral clinical psychology internship at the Central Texas Veterans Health Care
System. The predoctoral clinical psychology internship includes three major rotations,
which are four days a week for three months each, two minor rotations, which are one
half day a week for six months, and a half day of didactics/group supervision a week.
Major rotations included primary care/behavioral health, health behavior clinic, and
mental health clinic. Minor rotations included the psychosocial rehabilitation resource
center and the Post-Traumatic Stress Disorder clinic. Additional activities included case
conference write-up and presentation (assessment and intervention case), didactics (EBP
and general topics relevant to clinical psychology and working in the VA), group
supervision, diversity seminar, interdisciplinary professional training presentations, and
staff meetings.
Training Directors: Andrew Cook, Ph.D. and Erin Andrews, Psy.D., ABPP
April 2016-July 2016
Predoctoral clinical psychology internship
The mental health clinic major rotation includes consultation intakes, individual therapy,
group therapy (facilitating acceptance and commitment therapy (ACT) for anxiety and
depression and co-facilitating cognitive processing therapy (CPT) for sexual trauma),
treatment planning, consultation, staff meetings, chart review/clinical report writing,
reading, and one-on-one supervision.
Supervised by Kentrell Avery, Psy.D.

	
  

181

	
  
February 2016-July 2016
Predoctoral clinical psychology internship
The Post-Traumatic Stress Disorder clinic minor rotation includes individual therapy
(coping skills for PTSD, CPT, and prolonged exposure), treatment planning, chart
review/clinical report writing, reading, and one-on-one supervision.
Supervised by Regina Hiraoka, Ph.D.
November 2015-March 2016
Predoctoral clinical psychology internship
The health behavior clinic major rotation included presurgical evaluations (transplant and
bariatric), consultation intakes and individual therapy (CBT-insomnia, CBT-chronic pain,
and chronic disease management), co-facilitating group therapy (MOVE weight
management, CBT-insomnia, tobacco cessation, disease management), treatment
planning, consultation, national conference calls, case conferences and presentation, staff
meetings, co-facilitating motivational interviewing and TEACH trainings, audio
recordings, chart review/clinical report writing, reading, and one-on-one supervision.
Supervised by Andrew Cook, Ph.D.
July 2015-January 2016
Predoctoral clinical psychology internship
The psychosocial resource and recovery center minor rotation included treatment
planning sessions, recovery coaching, individual therapy, co-facilitating group therapy
(mindfulness for depression and stress management), treatment planning, staff meetings,
audio recording, chart review/clinical report writing, reading, and one-on-one
supervision. This clinic population includes Veterans with long-term severe mental
illness needs.
Supervised by Jennifer Rigsby, Ph.D.
July 2015-November 2015
Predoctoral clinical psychology internship
The primary care/behavioral health major rotation included consultation intakes, brief
solution-focused therapy, consultation-liaison, co-facilitating group therapy (CBTinsomnia, CBT-chronic pain, and mindfulness-based stress reduction), staff meetings,
audio recording, chart review/clinical report writing, reading, and one-on-one
supervision.
Supervised by Claudia Goleburn, Psy.D.
August 2014-June 2015
Graduate program practicum
Clinical practicum learning Cognitive-Behavioral therapeutic interventions with a focus
on treatment of anxiety disorders in adults and children. Weekly team supervision, peer
consultation, one-on-one supervision, intakes, assessments, individual therapy, group
therapy, case conceptualization, audio/visual digital recording review, chart
review/clinical report writing, and reading are activities that are included.
Supervised by Janet Woodruff-Borden, Ph.D.
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May 2014-June 2015
Clinic Graduate Teaching Assistant
Graduate teaching assistant at the Noble H. Kelley Psychological Services Center, a
graduate student run clinic at the University of Louisville. Responsibilities include
coordinating the PSC colloquium series, opening and closing the clinic, checking in
clients for appointments, phone intakes for therapy and assessment clients, clinical
interviews/intakes with prospective therapy clients; supervision of graduate students;
one-on-one supervision, chart review, report writing, and audio/visual digital recording
review are activities that are included.
Supervised by Bernadette Walter, Ph.D.
April 2014-June 2015
Graduate program practicum
Neuropsychology practicum learning how to conduct dementia assessments. Clinical
interviewing, administration of neuropsychological assessment battery, collateral
interview, one-on-one supervision, chart review/assessment report writing, and reading
are all activities that are included. Additional opportunities to complete surgical
evaluations (i.e., cochlear implant), conduct cognitive assessments in children with
possible central auditory processing disorder, and work with therapy clients are included.
Supervised by Elizabeth Cash, Ph.D. and Eric Russ, Ph.D.
August 2013-August 2014
Graduate program practicum
Clinical practicum learning Behavioral/Cognitive-Behavioral therapeutic interventions
with a focus on treatment of ADHD and emotional difficulties in children. Weekly team
supervision, peer consultation, one-on-one supervision, intakes, assessments, individual
therapy, group therapy, case conceptualization, audio/visual digital recording review,
chart review/clinical report writing, and reading are activities that are included.
Supervised by Paul Rosen, Ph.D.
May 2013-May 2014
Graduate program practicum
Head and neck cancer clinic practicum learning how to conduct health and behavior
assessments and medical/health related interventions for newly diagnosed patients.
Clinical interviewing, administration of self-report questionnaires, consultation/liaison
work, evaluations (e.g., cochlear implant), one-on-one supervision, chart
review/assessment report writing, program development, and reading are activities that
are included.
Supervised by Elizabeth Cash, Ph.D. and Eric Russ, Ph.D.
May 2012-June 2015
Graduate program practicum
Assessment practicum learning how to conduct ADHD and learning disability testing for
adults. Clinical interviewing, administration of standardized testing, one-on-one
supervision, chart review/clinical report writing, and reading are activities that are
included.
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Supervised by David Winsch, Ph.D.
May 2012-June 2015
Graduate program practicum
Assessment practicum learning how to conduct advanced placement testing for children.
Clinical interviewing of parents/legal guardians, administration of standardized testing,
one-on-one supervision, chart review/clinical report writing, and reading are activities
that are included.
Supervised by Bernadette Walter, Ph.D.
August 2011-August 2013
Graduate program practicum
Clinical practicum learning a Mindfulness approach to therapeutic interventions,
primarily working with adults with mood disorders. Weekly team supervision, peer
consultation, one-on-one supervision, individual therapy, case conceptualization,
audio/visual digital recording review, chart review/clinical report writing, and reading are
activities that are included.
Supervised by Paul Salmon, Ph.D.
Teaching Experience
2011-2015
Graduate Teaching Assistant, University of Louisville Department of Psychological and
Brain Sciences
Courses Assisted: Psychology 385: Abnormal Psychology; Psychology 344:
Physiological Psychology; Psychology 443: Intro to Neuroscience; Psychology 302:
Experimental Psychology (including teaching recitations); Psychology 372: Social
Psychology; Psychology 375: Personality; Psychology 693: Interviewing Skills
Practicum; Psychology 680: Intellectual and Cognitive Assessment
Community Service & Volunteer Experience
Peer Reviewer: American Psychosomatic Society
Conference Abstracts

November 2015

Athena’s Sisters Empowerment Workshop
“I am woman, hear me roar”

Louisville, KY
May 11, 2015

Peer Reviewer: American Psychosomatic Society
Conference Abstracts

November 2014

Psychiatry Resident Lecture
Topic: Geriatric Neuropsychological Assessment

Louisville, KY
October 2014

Peer Reviewer: Psychosomatic Medicine

October 2014

Peer Reviewer: Psycho-Oncology

June 2014
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Cohort Liaison to the Faculty

October 2013-September 2014

Dress for Success Talk
Topic: Stress Management and Your Career

Louisville, KY
June 18, 2013

Dress for Success Health Fair
Psychological Services Center Representative

Louisville, KY
November 10, 2012

Heart Walk Volunteer
American Heart Association

Louisville, KY
September 22, 2012

St. James Catholic Church
Volunteer

Louisville, KY
Winter 2011

University of Louisville
Disability Resource Center Note Taker

Louisville, KY
Fall 2010

Children’s Hospital Foundation
Teen Advisory Board President

Louisville, KY
Summer 2006-Spring 2007

National Youth Leadership Forum
Medical Outreach Program

Atlanta, GA
July 25-29, 2006

Professional Membership
APA Division 29- Psychotherapy
APA Division 38- Health Psychology
American Psychological Association
APAGS-Campus Representative
Kentucky Psychological Association
American Psychosomatic Society
Psi Chi International Honor Society in Psychology
Vice President and Historian: UofL Chapter
Fundraising Coordinator: UofL Chapter

Summer 2013-Summer 2014
Summer 2013-Present
Summer 2011-Present
August 2013-August 2014
Summer 2011-Present
Spring 2011-Present
Inducted Spring 2010
Fall 2010-Summer 2011
Fall 2009-Summer 2010
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